{"PMC7451008": [["INTRODUCTIONThe first coronavirus case in Finland was diagnosed for a Chinese tourist in a holiday resort in Lapland on January 29th, 2020.", [["coronavirus", "ORGANISM", 22, 33]]], ["On February 13rd, 2020 COVID-19 infection was included in the list of generally hazardous communicable diseases by amending the Government Decree on Communicable Diseases.", [["infection", "DISEASE", 32, 41], ["communicable diseases", "DISEASE", 90, 111], ["COVID-19", "CELL", 23, 31], ["infection", "PROBLEM", 32, 41], ["generally hazardous communicable diseases", "PROBLEM", 70, 111], ["infection", "OBSERVATION", 32, 41], ["hazardous", "OBSERVATION_MODIFIER", 80, 89], ["communicable diseases", "OBSERVATION", 90, 111]]], ["However, the situation with the spread of COVID-19 in Finland started to evolve only in early March, boosted by travel to the Alps during the winter holidays in February.INTRODUCTIONCOVID-19 epidemic was considered to have started in Finland in mid-March soon after the WHO had announced the COVID-19 outbreak as a pandemic.", [["COVID-19", "CHEMICAL", 42, 50], ["COVID", "TEST", 42, 47], ["the COVID", "TEST", 288, 297]]], ["On March 16th 2020 the Finnish Government announced a state of emergency due to the coronavirus outbreak and consequently implemented several physical distancing measures aimed at slowing the spread and protecting risk groups.INTRODUCTIONSo far, Finland has been successful in restraining the pandemic.", [["coronavirus", "DISEASE", 84, 95], ["coronavirus", "ORGANISM", 84, 95], ["the coronavirus outbreak", "PROBLEM", 80, 104], ["several physical distancing measures", "TREATMENT", 134, 170], ["coronavirus", "OBSERVATION", 84, 95]]], ["That allowed early implementation of restrictive regulations and recommendations.", [["restrictive regulations", "TREATMENT", 37, 60]]], ["However, these measures which have been obeyed well by the population have probably had several negative, unintended consequences.INTRODUCTIONThis paper provides an overview of Finland's healthcare system, COVID-19 trends, policy interventions, health response data and the economic and financial impact of the pandemic.", [["COVID", "TREATMENT", 206, 211], ["policy interventions", "TREATMENT", 223, 243], ["health response data", "TEST", 245, 265], ["negative", "OBSERVATION", 96, 104]]], ["Data were collected from various sources, including governments and ministerial reports, newspaper articles and international databases, such as the COVID-19 Health System Response Monitor by the European Observatory on Health Systems and Policies and OECD country and coronavirus web service to understand the development of the pandemic and the policy interventions to address the pandemic.", [["the policy interventions", "TREATMENT", 343, 367], ["the pandemic", "PROBLEM", 379, 391]]], ["The municipalities have the right to levy taxes.", [["right", "ANATOMY_MODIFIER", 28, 33]]], ["The municipalities can organize health care for their residents themselves or the service can be organized in collaboration with another municipality or a joint municipal authority.", [["joint", "ANATOMY", 155, 160]]], ["(3,4)Finnish health system overview ::: COUNTRY DESCRIPTIONThe national hospital system delivers high quality care for acute conditions, but recognized challenges have been to improve primary care for a growing number of people with chronic conditions, to promote greater coordination between primary care and hospitals.", [["people", "ORGANISM", 221, 227], ["people", "SPECIES", 221, 227], ["acute conditions", "PROBLEM", 119, 135], ["chronic conditions", "PROBLEM", 233, 251]]], ["This means that any measures implemented in the public health system due to the epidemic are in the first instance funded by municipalities.", [["any measures", "TREATMENT", 16, 28], ["epidemic", "OBSERVATION", 80, 88]]], ["However, while the municipal sector overall has run in deficit and in recent years a growing number of municipalities have had difficulties with managing their responsibilities, the government has released financial aid to support municipalities with the COVID-19 pandemic.", [["deficit", "PROBLEM", 55, 62], ["the COVID", "TEST", 251, 260], ["deficit", "OBSERVATION", 55, 62], ["growing", "OBSERVATION_MODIFIER", 85, 92]]], ["(1)Finnish health system overview ::: COUNTRY DESCRIPTIONSome larger municipalities such as the cities of Helsinki and Tampere have assigned special clinics to patients with respiratory symptoms to make the use of services safer (1).", [["respiratory", "ANATOMY", 174, 185], ["respiratory symptoms", "DISEASE", 174, 194], ["patients", "ORGANISM", 160, 168], ["patients", "SPECIES", 160, 168], ["respiratory symptoms", "PROBLEM", 174, 194]]], ["The five university hospital districts are legally obliged to plan and coordinate care in their catchment areas, while all hospital districts and municipalities are responsible for epidemic preparedness and management in their respective geographical areas.Finnish health system overview ::: COUNTRY DESCRIPTIONFinland does not have a specific agency mandated for active engagement, policy implementation and oversight of the epidemic, which caused confusion especially in the beginning.", [["confusion", "DISEASE", 449, 458], ["epidemic preparedness", "TREATMENT", 181, 202], ["management", "TREATMENT", 207, 217], ["confusion", "PROBLEM", 449, 458]]], ["The distribution of work between municipalities and hospital districts has remained normal.", [["hospital districts", "TEST", 52, 70], ["distribution", "OBSERVATION_MODIFIER", 4, 16], ["normal", "OBSERVATION", 84, 90]]], ["(1)Risk factors of health ::: COUNTRY DESCRIPTIONFor the Finnish population, life expectancy has increased by nearly four years since 2000, but many of the additional years are spent with some chronic diseases and disabilities, raising demands on health and long-term care systems.", [["chronic diseases and disabilities", "DISEASE", 193, 226], ["some chronic diseases and disabilities", "PROBLEM", 188, 226], ["long-term care systems", "TREATMENT", 258, 280], ["increased", "OBSERVATION_MODIFIER", 97, 106], ["chronic", "OBSERVATION_MODIFIER", 193, 200], ["diseases", "OBSERVATION", 201, 209]]], ["Trends show that the share of people aged 65 and over is steadily growing because of rising life expectancy and declining fertility rates.", [["people", "ORGANISM", 30, 36], ["people", "SPECIES", 30, 36], ["rising life expectancy", "PROBLEM", 85, 107], ["declining fertility rates", "PROBLEM", 112, 137]]], ["In 2017, 21% of the population was aged 65 years old and over which is notable as COVID-19 infection is more risky for the elderly people.", [["infection", "DISEASE", 91, 100], ["people", "ORGANISM", 131, 137], ["people", "SPECIES", 131, 137], ["COVID", "TEST", 82, 87], ["infection", "PROBLEM", 91, 100], ["infection", "OBSERVATION", 91, 100]]], ["(5,6) Three in five of those aged 65 or over reported having at least one chronic condition or disability, which is a higher proportion than in the EU on average.", [["disability", "DISEASE", 95, 105], ["chronic", "OBSERVATION_MODIFIER", 74, 81], ["condition", "OBSERVATION", 82, 91], ["disability", "OBSERVATION", 95, 105], ["higher", "OBSERVATION_MODIFIER", 118, 124], ["proportion", "OBSERVATION_MODIFIER", 125, 135]]], ["While most people can continue to live independently in old age, one in eight reports some limitations in activities of daily living.", [["people", "ORGANISM", 11, 17], ["people", "SPECIES", 11, 17]]], ["(3) There are regional variations in demographics and morbidity across different regions in Finland (7).Risk factors of health ::: COUNTRY DESCRIPTIONThe socioeconomic disparities in health and life expectancy remain large, mainly due to preventable risk factors.", [["regional variations in demographics", "PROBLEM", 14, 49], ["morbidity", "PROBLEM", 54, 63], ["preventable risk factors", "PROBLEM", 238, 262], ["regional", "OBSERVATION_MODIFIER", 14, 22], ["variations", "OBSERVATION_MODIFIER", 23, 33], ["different", "OBSERVATION_MODIFIER", 71, 80], ["regions", "OBSERVATION_MODIFIER", 81, 88], ["large", "OBSERVATION", 217, 222]]], ["A socioeconomic gradient can be seen in smoking, where progress has been made, but excessive alcohol use and alcohol use in general remain problems.", [["alcohol", "CHEMICAL", 93, 100], ["alcohol", "CHEMICAL", 109, 116], ["alcohol", "CHEMICAL", 93, 100], ["alcohol", "CHEMICAL", 109, 116], ["alcohol", "SIMPLE_CHEMICAL", 109, 116], ["A socioeconomic gradient", "PROBLEM", 0, 24]]], ["(2) Approximately 20% of the population is obese, which is a growing public health issue due to physical inactivity and poor nutrition habits.", [["obese", "PROBLEM", 43, 48], ["physical inactivity", "PROBLEM", 96, 115], ["poor nutrition habits", "PROBLEM", 120, 141], ["obese", "OBSERVATION", 43, 48], ["growing", "OBSERVATION_MODIFIER", 61, 68]]], ["(2) The incidence of diabetes is high and there are approximately 400,000 diabetics in Finland: 50,000 (T1D) and 350,000 (T2D).", [["diabetes", "DISEASE", 21, 29], ["T1D", "DISEASE", 104, 107], ["T2D", "DISEASE", 122, 125], ["diabetes", "PROBLEM", 21, 29], ["diabetes", "OBSERVATION", 21, 29], ["high", "OBSERVATION_MODIFIER", 33, 37]]], ["In addition, an approximately 100,000 Finns suffer from T2D without knowing it.", [["T2D", "DISEASE", 56, 59], ["T2D", "PROBLEM", 56, 59]]], ["(8) The Finnish population features, risk factors and health system overview are summarized in Table 1.Overview of data availability and data transparency ::: COVID-19 TRENDSWhile the Finnish Institute for Health and Welfare (THL) is the main national statistical and registry authority for the health and social sector, it is also responsible for collecting the COVID-19 data.", [["COVID", "TEST", 159, 164], ["the COVID", "TEST", 359, 368]]], ["In the beginning the data on COVID-19 laboratory tests were collected directly from the laboratories and hospitals conducting the tests, but as the pandemic evolved the number of tests and test results are reported through the National Infectious Disease Register maintained by THL.", [["Infectious Disease", "DISEASE", 236, 254], ["THL", "CHEMICAL", 278, 281], ["COVID", "TEST", 29, 34], ["laboratory tests", "TEST", 38, 54], ["the tests", "TEST", 126, 135], ["tests", "TEST", 179, 184], ["test", "TEST", 189, 193]]], ["Due to a few days delay in recording the data in the Register, the most recent daily figures are not complete.Overview of data availability and data transparency ::: COVID-19 TRENDSThe numbers of COVID-19 patients treated in hospitals and intensive care units have been collected through the hospital districts.", [["patients", "ORGANISM", 205, 213], ["patients", "SPECIES", 205, 213], ["the data", "TEST", 37, 45], ["COVID", "TEST", 166, 171], ["COVID", "TEST", 196, 201], ["intensive care units", "TREATMENT", 239, 259]]], ["The districts also report data on COVID-19 related infections and deaths in their region.", [["infections", "DISEASE", 51, 61], ["deaths", "DISEASE", 66, 72], ["COVID", "TEST", 34, 39], ["infections", "OBSERVATION", 51, 61]]], ["THL and hospital districts report data on a different basis \u2013 THL reports data based on the patient's residence, while hospital districts report the test results that have been done in their area.", [["patient", "ORGANISM", 92, 99], ["patient", "SPECIES", 92, 99], ["the test", "TEST", 145, 153]]], ["The reporting system has functioned well, but in early days there was a misconception of the reporting responsibilities in some areas, which resulted in a later corrected failure in reporting deaths in elderly care institutions.", [["deaths", "DISEASE", 192, 198], ["a later corrected failure", "PROBLEM", 153, 178]]], ["The reporting has focused on cases confirmed by laboratory tests.", [["laboratory tests", "TEST", 48, 64]]], ["(1)Overview of data availability and data transparency ::: COVID-19 TRENDSThe COVID-19 data are released at the THL website.", [["COVID", "TEST", 59, 64], ["COVID", "TEST", 78, 83]]], ["The collected data have been published daily from the start of the pandemic.", [["The collected data", "TEST", 0, 18]]], ["THL has been criticized for not giving out detailed information on the deaths and patients treated in the hospitals (1).", [["THL", "CHEMICAL", 0, 3], ["deaths", "DISEASE", 71, 77], ["patients", "ORGANISM", 82, 90], ["patients", "SPECIES", 82, 90]]], ["For instance, the breakdown of the cases according to age and sex was not initially reported.", [["the breakdown of the cases", "PROBLEM", 14, 40]]], ["THL has also been criticized for not releasing the methodological details and assumptions used for modelling the epidemic (1).", [["THL", "CHEMICAL", 0, 3], ["THL", "SIMPLE_CHEMICAL", 0, 3]]], ["There are also no published data on contact tracing.COVID-19 cases, deaths, hospitalizations and recoveries ::: COVID-19 TRENDSThe first COVID-19 death in Finland was reported on 21st March.", [["deaths", "DISEASE", 68, 74], ["death", "DISEASE", 146, 151], ["contact tracing", "TEST", 36, 51], ["COVID", "TEST", 112, 117], ["no", "UNCERTAINTY", 15, 17]]], ["At the time 17 patients were in hospitalized and five of them treated at ICUs.", [["patients", "ORGANISM", 15, 23], ["patients", "SPECIES", 15, 23]]], ["At the national level the number of hospitalized patients peaked on the 8th and 9th of April when there were altogether 244 patients were hospitalized of which 82 were treated at ICUs.", [["patients", "ORGANISM", 49, 57], ["patients", "ORGANISM", 124, 132], ["patients", "SPECIES", 49, 57], ["patients", "SPECIES", 124, 132]]], ["(9)COVID-19 cases, deaths, hospitalizations and recoveries ::: COVID-19 TRENDSOn August 10, 2020 five patients were in hospital and one of them at ICU care.", [["deaths", "DISEASE", 19, 25], ["patients", "ORGANISM", 102, 110], ["patients", "SPECIES", 102, 110]]], ["By August 10, 2020 the number of COVID-19 cases reported was 7,464 and the number of deaths 333 and some 6,980 (over 90% of all reported cases) had recovered.", [["deaths", "DISEASE", 85, 91], ["COVID", "TEST", 33, 38]]], ["The numbers of COVID-19 cases in Finland are described in the following figures in detail (Figure 1, Figure 2).", [["COVID", "TEST", 15, 20]]], ["After the low rates in June- July 2020 the number of diagnosed COVID-19 cases have started to increase slightly in August according to the most recent reports.COVID-19 cases, deaths, hospitalizations and recoveries ::: COVID-19 TRENDSThe capital region has been the epidemic centre in Finland.", [["COVID", "DISEASE", 63, 68], ["deaths", "DISEASE", 175, 181], ["COVID", "TEST", 63, 68], ["COVID", "TEST", 219, 224], ["epidemic", "OBSERVATION_MODIFIER", 266, 274], ["centre", "OBSERVATION_MODIFIER", 275, 281]]], ["However, at the end of April 2020 the highest incidence of the COVID-19 infections was in the L\u00e4nsi-Pohja hospital district located in the North-West of Finland.", [["infections", "DISEASE", 72, 82], ["the COVID-19 infections", "PROBLEM", 59, 82], ["infections", "OBSERVATION", 72, 82], ["North", "ANATOMY_MODIFIER", 139, 144]]], ["The L\u00e4nsi-Pohja district also recorded the highest increase in COVID-19 incidence at that time while at the same time in most other hospital districts incidence rates were declining.", [["COVID", "TEST", 63, 68], ["highest", "OBSERVATION_MODIFIER", 43, 50], ["increase", "OBSERVATION_MODIFIER", 51, 59]]], ["(9) The area is bordering Sweden but according to the hospital district the high number of cases was due to a local outbreak.", [["a local outbreak", "PROBLEM", 108, 124], ["bordering", "OBSERVATION_MODIFIER", 16, 25], ["Sweden", "OBSERVATION", 26, 32], ["local", "OBSERVATION_MODIFIER", 110, 115], ["outbreak", "OBSERVATION", 116, 124]]], ["(10)COVID-19 cases, deaths, hospitalizations and recoveries ::: COVID-19 TRENDSParallel to the high number of the cases in the Helsinki region, over 80% of deaths and 70% of ICU treated patients have been located in the Helsinki University Hospital catchment area.", [["deaths", "DISEASE", 20, 26], ["deaths", "DISEASE", 156, 162], ["patients", "ORGANISM", 186, 194], ["patients", "SPECIES", 186, 194], ["COVID", "TEST", 64, 69], ["high number", "OBSERVATION_MODIFIER", 95, 106]]], ["To date, 41% of deaths have occurred in elderly care institutions and 38% in healthcare center wards usually treating elderly patients with multimorbidity, whereas 19% in hospitals.", [["deaths", "DISEASE", 16, 22], ["multimorbidity", "DISEASE", 140, 154], ["patients", "ORGANISM", 126, 134], ["patients", "SPECIES", 126, 134], ["multimorbidity", "PROBLEM", 140, 154]]], ["The numbers of COVID-19 incidence and daily number of laboratory-confirmed COVID-19 infection patients in intensive care units in Finland are described in Figures 3. and 4.Policies aimed at curbing spread, transmission and improving cure ::: POLICY AND TECHNOLOGY ROADMAPThe grounds for the preparedness and policy measures taken forward in Finland have been laid down in different policies (e.g. the National preparedness plan for an influenza pandemic), ordinary laws (Communicable Diseases Act) and legislation on emergency powers (the section 23 of the Constitution, and the Emergency Powers Act).", [["infection", "DISEASE", 84, 93], ["influenza pandemic", "DISEASE", 435, 453], ["patients", "ORGANISM", 94, 102], ["patients", "SPECIES", 94, 102], ["COVID", "TEST", 15, 20], ["COVID", "TEST", 75, 80], ["policy measures", "TREATMENT", 308, 323], ["an influenza pandemic", "PROBLEM", 432, 453], ["infection", "OBSERVATION", 84, 93]]], ["Different policies have been implemented in Finland widely to stop the spread of the COVID-19 pandemic (table 2).Policies aimed at curbing spread, transmission and improving cure ::: POLICY AND TECHNOLOGY ROADMAPMuch of Finland's response to the COVID-19 pandemic has been based on legal measures other than actual emergency powers, namely on recommendations to the public and legally binding orders in accordance with e.g. the Communicable Diseases Act or through \u201csoft\u201d recommendations to the public and employers.Policies aimed at curbing spread, transmission and improving cure ::: POLICY AND TECHNOLOGY ROADMAPThe Government took stricter measures to stop the spread as the epidemic situation evolved by introducing \u201charder\u201d, unilateral, decisions by public authorities.", [["the COVID", "TEST", 81, 90], ["the COVID", "TREATMENT", 242, 251], ["legal measures", "TREATMENT", 282, 296], ["stricter measures", "TREATMENT", 635, 652]]], ["When COVID-19 was listed as a generally hazardous communicable disease by the Government Decree in February, the authorities were given special powers as included in the Communicable Diseases Act.", [["communicable disease", "DISEASE", 50, 70], ["COVID-19", "DNA", 5, 13], ["a generally hazardous communicable disease", "PROBLEM", 28, 70]]], ["Under the Emergency Powers Act municipalities and hospital districts could also deviate from the time limits for non-urgent healthcare, except for the assessment of the need for care.Policies aimed at curbing spread, transmission and improving cure ::: POLICY AND TECHNOLOGY ROADMAPRegarding the impact of policy intervention in Finland it is estimated that incidence of COVID-19 decreased by 13% on the average in relation to physical distancing interventions.", [["the assessment", "TEST", 147, 161], ["policy intervention", "TREATMENT", 306, 325], ["COVID", "TEST", 371, 376], ["physical distancing interventions", "TREATMENT", 427, 460]]], ["The implementation of lockdown early in the epidemic compared to many other countries was also obviously associated with the incidence of COVID-19.", [["COVID", "TEST", 138, 143]]], ["No evidence of additional benefits has been found from the closure of public transport when four other physical distancing measures (school disclosures, workplace closures, restrictions on mass gatherings, and lockdown) were in place.\u201d (11) Table 3. shows the dates of the first laboratory confirmed COVID-19 infections, legally activated restrictive measures infectious disease in Finland and selected EU Member States.", [["infections", "DISEASE", 309, 319], ["infectious disease", "DISEASE", 360, 378], ["public transport", "TREATMENT", 70, 86], ["COVID-19 infections", "PROBLEM", 300, 319], ["legally activated restrictive measures infectious disease", "PROBLEM", 321, 378], ["evidence of", "UNCERTAINTY", 3, 14], ["closure", "OBSERVATION", 59, 66], ["infections", "OBSERVATION", 309, 319], ["restrictive", "OBSERVATION_MODIFIER", 339, 350]]], ["(12, 13, 14)Practices aimed to curb spread, and to aid prevention and cure ::: POLICY AND TECHNOLOGY ROADMAPTHL has given general advice on hand hygiene, physical distancing and respiratory etiquette.", [["hand", "ANATOMY", 140, 144], ["respiratory", "ANATOMY", 178, 189], ["hand", "ORGANISM_SUBDIVISION", 140, 144], ["hand hygiene", "TREATMENT", 140, 152]]], ["THL has also produced materials for use by public health officials functioning at national and local level.", [["THL", "CHEMICAL", 0, 3], ["THL", "SIMPLE_CHEMICAL", 0, 3]]], ["THL updates its website daily which has a Q&A section and general information about the disease, prevention and care for the public, health care professionals as well as for the media.", [["THL", "CHEMICAL", 0, 3], ["THL", "SIMPLE_CHEMICAL", 0, 3], ["the disease", "PROBLEM", 84, 95]]], ["Also the Finnish Institute of Occupational Health (TTL) has provided guidelines on preventing coronavirus infections in the workplace for all workplaces and workers (15).Practices aimed to curb spread, and to aid prevention and cure ::: POLICY AND TECHNOLOGY ROADMAPOne of the areas the guidance has been given and changed is the use of PPE in health and social care to protect the clients.", [["coronavirus infections", "DISEASE", 94, 116], ["coronavirus", "ORGANISM", 94, 105], ["coronavirus infections", "PROBLEM", 94, 116], ["social care", "TREATMENT", 355, 366]]], ["(16) The aim is to protect clients with increased risk to serious COVID-19 infection.", [["infection", "DISEASE", 75, 84], ["serious COVID-19 infection", "PROBLEM", 58, 84], ["infection", "OBSERVATION", 75, 84]]], ["Oral health care workers need to have the highest level of PPE (17).", [["Oral", "ANATOMY", 0, 4]]], ["There has been considerable debate about the use of face masks.", [["face masks", "TREATMENT", 52, 62], ["considerable", "OBSERVATION_MODIFIER", 15, 27]]], ["For the general public THL and MSAH have stated that fabric face masks can be used in places where it is not possible to avoid close contact.", [["fabric face masks", "TREATMENT", 53, 70]]], ["(1) In mid-August 2020, after new increase in the COVID-19 incidence, THL released a firmer recommendation on the use of face mask in public transport as well as in cases with suspicion on the infection, such returning to Finland from high incidence country.", [["THL", "CHEMICAL", 70, 73], ["infection", "DISEASE", 193, 202], ["THL", "SIMPLE_CHEMICAL", 70, 73], ["face mask", "TREATMENT", 121, 130], ["public transport", "TREATMENT", 134, 150], ["the infection", "PROBLEM", 189, 202], ["new", "OBSERVATION_MODIFIER", 30, 33], ["increase", "OBSERVATION_MODIFIER", 34, 42], ["infection", "OBSERVATION", 193, 202]]], ["(18)Testing strategies and implemented technology ::: POLICY AND TECHNOLOGY ROADMAPTesting and tracing has been an important element of the Finnish strategy along the way but its role has been emphasized since May 2020 when the government stated that Finland adopts a \u201chybrid strategy\u201d \u2013 as they call it \u2013 referring to a move from extensive restrictive measures to enhanced management of the pandemic.", [["extensive restrictive measures", "TREATMENT", 331, 361], ["enhanced management", "TREATMENT", 365, 384], ["the pandemic", "PROBLEM", 388, 400]]], ["Alongside the controlled dismantling of restrictive measures, the strategy focuses on testing, tracing, isolating and treating.", [["restrictive measures", "TREATMENT", 40, 60], ["testing", "TEST", 86, 93], ["tracing", "TEST", 95, 102], ["controlled", "OBSERVATION_MODIFIER", 14, 24], ["dismantling", "OBSERVATION_MODIFIER", 25, 36], ["restrictive", "OBSERVATION", 40, 51]]], ["In the public sector, symptomatic patients are tested in drive-troughs that are linked to hospitals.", [["patients", "ORGANISM", 34, 42], ["patients", "SPECIES", 34, 42], ["symptomatic", "OBSERVATION_MODIFIER", 22, 33]]], ["The public sector has bought testing capacity and drive-through testing also from the private sector.", [["testing capacity", "TEST", 29, 45]]], ["Private providers have provided testing services both to the public sector as well to individual citizens paying themselves.", [["testing services", "TREATMENT", 32, 48]]], ["(1)Testing strategies and implemented technology ::: POLICY AND TECHNOLOGY ROADMAPContact tracing is also done by local and regional authorities and decentralized tracing has been successful.", [["ROADMAPContact tracing", "TEST", 75, 97], ["decentralized tracing", "TEST", 149, 170]]], ["In most parts of the country the spread of the virus has potentially been limited due to effective tracing when cases have occurred.", [["the virus", "PROBLEM", 43, 52]]], ["THL has collected a pool of voluntary trackers who can be used to coordinate resources in case areas in Finland lack tracing capacity.", [["THL", "CHEMICAL", 0, 3]]], ["(1)Testing strategies and implemented technology ::: POLICY AND TECHNOLOGY ROADMAPTesting criteria has changed along the way and there have been regional differences in testing.", [["testing", "TEST", 169, 176], ["regional", "OBSERVATION_MODIFIER", 145, 153], ["differences", "OBSERVATION_MODIFIER", 154, 165]]], ["National steering has been the responsibility of THL.", [["THL", "CHEMICAL", 49, 52], ["THL", "CANCER", 49, 52]]], ["However, on March 12th, due to limited testing capacity, THL issued guidance on focusing testing on patients with severe respiratory tract infection symptoms and on elderly and social and health care personnel.", [["respiratory tract", "ANATOMY", 121, 138], ["respiratory tract infection", "DISEASE", 121, 148], ["patients", "ORGANISM", 100, 108], ["tract", "ORGANISM_SUBDIVISION", 133, 138], ["patients", "SPECIES", 100, 108], ["limited testing capacity", "TEST", 31, 55], ["focusing testing", "TEST", 80, 96], ["severe respiratory tract infection symptoms", "PROBLEM", 114, 157], ["severe", "OBSERVATION_MODIFIER", 114, 120], ["respiratory tract", "ANATOMY", 121, 138], ["infection", "OBSERVATION", 139, 148]]], ["When capacity allowed, testing was also performed on people with mild symptoms, those returning from abroad and vulnerable patient groups with an underlying condition and to people over the age of 70.", [["people", "ORGANISM", 53, 59], ["patient", "ORGANISM", 123, 130], ["people", "ORGANISM", 174, 180], ["people", "SPECIES", 53, 59], ["patient", "SPECIES", 123, 130], ["people", "SPECIES", 174, 180], ["testing", "TEST", 23, 30], ["mild symptoms", "PROBLEM", 65, 78], ["an underlying condition", "PROBLEM", 143, 166]]], ["(1) Hospital districts and other actors, for example the private sector, could test other suspected cases of COVID-19 if they deemed it necessary.Testing strategies and implemented technology ::: POLICY AND TECHNOLOGY ROADMAPOn April 15th, with increased testing capacity, THL and hospital districts redefined the official guidelines to promote more aggressive testing and identification of all symptomatic COVID-19 patients, including those with mild symptoms.", [["patients", "ORGANISM", 416, 424], ["patients", "SPECIES", 416, 424], ["COVID", "TEST", 109, 114], ["increased testing capacity", "PROBLEM", 245, 271], ["aggressive testing", "TEST", 350, 368], ["mild symptoms", "PROBLEM", 447, 460]]], ["As of 10 June, no untargeted testing of the asymptomatic population is conducted but the testing criteria are loosened and everyone with even mild symptoms and those suspected of being infected are tested at the physicians\u2019 discretion.", [["untargeted testing", "TEST", 18, 36], ["the asymptomatic population", "PROBLEM", 40, 67], ["the testing criteria", "TEST", 85, 105], ["even mild symptoms", "PROBLEM", 137, 155], ["infected", "OBSERVATION", 185, 193]]], ["Even though testing capacity has been increased, to date full capacity has not been in use.", [["testing capacity", "TEST", 12, 28], ["increased", "OBSERVATION_MODIFIER", 38, 47]]], ["The waiting-times to tests and for results have increased during the past month.", [["tests", "TEST", 21, 26], ["increased", "OBSERVATION_MODIFIER", 48, 57]]], ["The reasons for this relate to both supply and demand of the tests.", [["the tests", "TEST", 57, 66]]], ["On the demand side, losing many of the restrictions, start of the school year as well as day care have increased the number of flu cases which, under current guidelines, all need to be tested.", [["flu", "DISEASE", 127, 130]]], ["Children with minor flu, for instance, are not allowed to school or daycare without a negative test result.", [["Children", "ORGANISM", 0, 8], ["Children", "SPECIES", 0, 8], ["minor flu", "PROBLEM", 14, 23], ["flu", "OBSERVATION", 20, 23]]], ["Figure 5. shows the daily numbers of COVID-19 laboratory tests by laboratory specimen sampling date reported to the Finnish National Infectious Disease Register by August 10, 2020.Using health technology ::: POLICY AND TECHNOLOGY ROADMAPThe COVID-19 digital self-assessment tool Omaolo (omaolo.fi/en) is used nationwide and it is available in Finnish, Swedish and English.", [["Infectious Disease", "DISEASE", 133, 151], ["COVID", "TEST", 37, 42], ["laboratory tests", "TEST", 46, 62], ["COVID", "TEST", 241, 246], ["Omaolo (omaolo", "TREATMENT", 279, 293]]], ["Municipalities and hospital districts direct people to contact Omaolo on their websites.", [["people", "ORGANISM", 45, 51], ["people", "SPECIES", 45, 51]]], ["In practice, if a person suspects that they have COVID-19 infection, they are advised to make a COVID-19 symptom assessment using the Omaolo website.", [["infection", "DISEASE", 58, 67], ["person", "SPECIES", 18, 24], ["COVID-19 infection", "PROBLEM", 49, 67], ["symptom assessment", "TEST", 105, 123], ["infection", "OBSERVATION", 58, 67]]], ["If a person is deemed, according to their symptoms, as potentially having COVID-19 infection they are advised to contact their own health centre.", [["infection", "DISEASE", 83, 92], ["person", "SPECIES", 5, 11], ["their symptoms", "PROBLEM", 36, 50], ["COVID-19 infection", "PROBLEM", 74, 92], ["infection", "OBSERVATION", 83, 92]]], ["The patients who have sent their questionnaire to a health care provider can be then contacted by a nurse or a physician.Using health technology ::: POLICY AND TECHNOLOGY ROADMAPFor Omaolo, some 600,000 questionnaires have been assessed since March 2020.", [["patients", "ORGANISM", 4, 12], ["patients", "SPECIES", 4, 12]]], ["Among the 60-69-year old, the responses were 7% of all the self-assessments and 9% of the COVID-19 infections whereas 13% in the general population.", [["infections", "DISEASE", 99, 109], ["COVID-19", "SPECIES", 90, 98], ["the COVID", "TEST", 86, 95], ["infections", "PROBLEM", 99, 109]]], ["The proportions were 3%, 12% and 16%, among those at least 70 year old people, respectively.", [["people", "ORGANISM", 71, 77], ["people", "SPECIES", 71, 77]]], ["(21)Using health technology ::: POLICY AND TECHNOLOGY ROADMAPGood practices related to COVID-19 related measures implemented in the municipal sector have been collected to an open access Innokyl\u00e4 website moderated by THL (innokyla.fi) in order to share information between municipalities.", [["THL", "CHEMICAL", 217, 220], ["THL", "SIMPLE_CHEMICAL", 217, 220], ["COVID", "TEST", 87, 92]]], ["In addition, the recently launched national emergency assessment medical Helpline 116117 has been used.", [["Helpline 116117", "CHEMICAL", 73, 88], ["Helpline 116117", "CHEMICAL", 73, 88]]], ["There are also some early experiences of using other health technologies and applications with COVID-19 epidemic.Using health technology ::: POLICY AND TECHNOLOGY ROADMAPTo support contact tracing the Parliament has enacted amendments to the Communicable Diseases Act that enable the development of a system for contacting people who may have been exposed to COVID-19.", [["COVID-19", "CHEMICAL", 359, 367], ["people", "ORGANISM", 323, 329], ["people", "SPECIES", 323, 329], ["COVID", "TEST", 95, 100], ["COVID", "TEST", 359, 364], ["some", "OBSERVATION_MODIFIER", 15, 19], ["early", "OBSERVATION_MODIFIER", 20, 25]]], ["The application (Koronavilkku) would be used to alert people who have come into contact with someone who have tested positive and people could send information on their potential exposure to the healthcare service and quickly receive information on actions that they need to take.", [["people", "ORGANISM", 54, 60], ["people", "ORGANISM", 130, 136], ["people", "SPECIES", 54, 60], ["people", "SPECIES", 130, 136], ["The application (Koronavilkku)", "TREATMENT", 0, 30]]], ["The use of application would be anonymous, free and voluntary.", [["application", "TREATMENT", 11, 22]]], ["(1, 22) Table 4presents the technology that has been implemented during the pandemic.Policies aimed to contain the economic impact ::: POLICY AND TECHNOLOGY ROADMAPThe regular state budget for the year 2020 included some funding for preparing for large infectious disease outbreaks and other unforeseen events.", [["large infectious disease outbreaks", "PROBLEM", 247, 281], ["other unforeseen events", "PROBLEM", 286, 309], ["large", "OBSERVATION_MODIFIER", 247, 252], ["infectious", "OBSERVATION", 253, 263]]], ["However, it was soon realized that the planned reserves were not enough for the COVID-19 pandemic needs and the Government submitted a supplementary budget proposal of \u20ac398 million in March 2020.", [["the COVID-19 pandemic needs", "TREATMENT", 76, 103]]], ["It focused on covering expenses incurring from the COVID-19 pandemic and on easing the financial situation of firms by emergency measures.", [["the COVID", "TEST", 47, 56]]], ["The proposal contained also a substantial increase (\u20ac200 million) for unforeseen events.Policies aimed to contain the economic impact ::: POLICY AND TECHNOLOGY ROADMAPSince March, the Government has issued three other supplementary budgets.", [["unforeseen events", "PROBLEM", 70, 87], ["substantial", "OBSERVATION_MODIFIER", 30, 41], ["increase", "OBSERVATION_MODIFIER", 42, 50]]], ["As the first supplementary budget concentrated on emergency measures, the latter three contained also a strong economic stimulus package as well as substantial increases for social spending.", [["emergency measures", "TREATMENT", 50, 68], ["a strong economic stimulus package", "TREATMENT", 102, 136], ["strong", "OBSERVATION_MODIFIER", 104, 110], ["economic stimulus", "OBSERVATION", 111, 128], ["substantial", "OBSERVATION_MODIFIER", 148, 159], ["increases", "OBSERVATION_MODIFIER", 160, 169]]], ["Moreover, the supplementary budgets contained also substantial increases in State Guarantees, capital funding for Government agencies and enterprises as well as authorizations for future investment expenditures, which will not materialize as expenditure this year.", [["substantial", "OBSERVATION_MODIFIER", 51, 62], ["increases", "OBSERVATION_MODIFIER", 63, 72]]], ["Increased expenditure and plunge in tax income imply that Central Government borrowing will increase from \u20ac2 billion to near \u20ac20 billion this year.HEALTH CARE SYSTEM RESPONSEAfter the declaration of the Emergency Powers Act in March, the MSAH instructed all emergency care services to streamline their activities and hospitals to increase their ICU capacity.", [["Increased expenditure", "PROBLEM", 0, 21], ["expenditure", "OBSERVATION_MODIFIER", 10, 21], ["plunge", "OBSERVATION_MODIFIER", 26, 32], ["Central", "OBSERVATION_MODIFIER", 58, 65]]], ["This capacity increase was, for instance, done by converting operation theatres and recovery areas into intensive care units.", [["increase", "OBSERVATION_MODIFIER", 14, 22]]], ["Hospital districts also started to train surgical staff and ward staff in treating COVID-19 patients and working at ICUs.", [["COVID", "DISEASE", 83, 88], ["patients", "ORGANISM", 92, 100], ["patients", "SPECIES", 92, 100]]], ["These actions meant scaling back elective surgeries and other non-acute care.", [["scaling back elective surgeries", "TREATMENT", 20, 51], ["other non-acute care", "TREATMENT", 56, 76]]], ["At the time of writing hospital districts and municipalities have started to expand non-acute care activities after the epidemic situation has evolved and it has become clear that the overload in the care system has not been an acute threat \u2013 at least so far.", [["the overload in the care system", "PROBLEM", 180, 211], ["overload", "OBSERVATION", 184, 192], ["acute", "OBSERVATION_MODIFIER", 228, 233], ["threat", "OBSERVATION", 234, 240]]], ["(23) Authorities estimated that the capacity can be doubled if needed but there are no exact numbers publicly available.", [["the capacity", "PROBLEM", 32, 44]]], ["The Helsinki-Uusimaa hospital district responsible for the capital region and with most COVID-19 patients so far in Finland has evaluated that it has 84 ICU beds that can be dedicated to COVID-19 patients.", [["patients", "ORGANISM", 97, 105], ["patients", "ORGANISM", 196, 204], ["patients", "SPECIES", 97, 105], ["patients", "SPECIES", 196, 204], ["capital", "ANATOMY", 59, 66]]], ["In April, a statement was issued on the evaluation of the sufficiency of ICU capacity outside the Helsinki-Uusimaa region concluding that based on the contemporary understanding of the development of the epidemic the increased capacity should be sufficient to meet the needs of COVID-19 patients across the country.", [["patients", "ORGANISM", 287, 295], ["patients", "SPECIES", 287, 295], ["the evaluation", "TEST", 36, 50], ["the epidemic the increased capacity", "PROBLEM", 200, 235], ["COVID", "TREATMENT", 278, 283]]], ["(24)HEALTH CARE SYSTEM RESPONSEIn the context of the Emergency Powers Act there is a section on the work obligation for trained health care staff (also the retired under 68) that could be applied to secure a sufficient number of staff in the event of overload in the service system.", [["overload", "DISEASE", 251, 259], ["overload", "PROBLEM", 251, 259], ["overload", "OBSERVATION", 251, 259]]], ["The sufficiency of workforce has been secured through other means, such as reorganizing work, purchasing services from the private sector, and recruiting backup employees (26).HEALTH CARE SYSTEM RESPONSEDespite scaling back non-urgent services both at specialized care and in primary level services the municipalities are still responsible for necessary healthcare and medical treatment.", [["non-urgent services", "TREATMENT", 224, 243], ["medical treatment", "TREATMENT", 369, 386], ["sufficiency", "OBSERVATION_MODIFIER", 4, 15]]], ["MSAH has issued guidance stating that in a difficult epidemic situation, the priority of urgent care for patients should be emphasized, but that non-urgent treatment must always be provided if deemed necessary for the patient's health status.", [["MSAH", "CHEMICAL", 0, 4], ["patients", "ORGANISM", 105, 113], ["patient", "ORGANISM", 218, 225], ["patients", "SPECIES", 105, 113], ["patient", "SPECIES", 218, 225], ["urgent care", "TREATMENT", 89, 100], ["non-urgent treatment", "TREATMENT", 145, 165]]], ["(27) Emergency powers were used to allow municipalities and hospital districts to deviate from the time limits for non-urgent healthcare, except for the assessment of the need for care.", [["Emergency powers", "TREATMENT", 5, 21], ["the assessment", "TEST", 149, 163]]], ["(28)HEALTH CARE SYSTEM RESPONSEIt has been reported that the number of outpatient care appointments has decreased substantially (Figure 6.) and this has not been compensated by the increase in digital appointments (29).", [["increase", "OBSERVATION_MODIFIER", 181, 189]]], ["This has raised concerns on potential increase in unmet care needs and the negative effects of postponing treatment.", [["postponing treatment", "TREATMENT", 95, 115], ["increase", "OBSERVATION_MODIFIER", 38, 46]]], ["In April 2020, THL published a rapid assessment on the effects of COVID-19 epidemic on the population's service needs, the service system and the economy (30).", [["a rapid assessment", "TEST", 29, 47], ["COVID", "TEST", 66, 71]]], ["According to the assessment, the range of services has been narrowed and the service forms have been altered to emphasize remote services.", [["the assessment", "TEST", 13, 27], ["narrowed", "OBSERVATION", 60, 68]]], ["For this reason - and also because of patients\u2019 fears - many necessary services requiring contact have not been realized, such as follow-up visits for people with long-term illnesses.", [["patients", "ORGANISM", 38, 46], ["people", "ORGANISM", 151, 157], ["patients", "SPECIES", 38, 46], ["people", "SPECIES", 151, 157], ["long-term illnesses", "PROBLEM", 163, 182]]], ["Also, the waiting times to non-urgent specialized care have substantially increased in all hospital districts (Figure 7.), even though the acute threat of the overload of the health care systems has potentially been realism only in the capital region.", [["non-urgent specialized care", "TREATMENT", 27, 54], ["the overload of the health care systems", "PROBLEM", 155, 194], ["increased", "OBSERVATION_MODIFIER", 74, 83], ["acute", "OBSERVATION_MODIFIER", 139, 144], ["overload", "OBSERVATION", 159, 167], ["capital", "ANATOMY_MODIFIER", 236, 243], ["region", "ANATOMY_MODIFIER", 244, 250]]], ["This has been suggested to exacerbate potentially the population's disease load, to prolong treatments, and to increase treatment costs after the epidemic has come to an end.", [["the population's disease load", "PROBLEM", 50, 79], ["prolong treatments", "TREATMENT", 84, 102], ["treatment costs", "TREATMENT", 120, 135]]], ["(30)HEALTH CARE SYSTEM RESPONSEThe epidemic has also affected the sales and purchases on medicine.", [["(30)", "CHEMICAL", 0, 4]]], ["On week 12, which was the week when the state of emergency was declared, the purchases of prescription medicine peaked in general (Figure 8.) and especially in medicine for respiratory diseases (ATC R) and in some other commonly used medicine groups.", [["respiratory", "ANATOMY", 173, 184], ["respiratory diseases", "DISEASE", 173, 193], ["prescription medicine", "TREATMENT", 90, 111], ["respiratory diseases", "PROBLEM", 173, 193], ["ATC R)", "TREATMENT", 195, 201], ["respiratory", "ANATOMY", 173, 184], ["diseases", "OBSERVATION", 185, 193]]], ["The purchases of anti-infectives for systemic use (ATC J) seem to have declined since the week 12 (Figure 9.) (31).", [["anti-infectives", "TREATMENT", 17, 32], ["systemic use (ATC J", "TREATMENT", 37, 56]]], ["The aim was to ensure the availability of medicinal products and essential medical supplies as well as the functioning of the distribution chain in Finland in the exceptional conditions caused by the coronavirus.March 2020: A turning point for the Finnish Economy ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDThe first economic effects of the pandemic emerged already before it had really started in Europe.", [["coronavirus", "DISEASE", 200, 211], ["coronavirus", "ORGANISM", 200, 211], ["medicinal products", "TREATMENT", 42, 60], ["essential medical supplies", "TREATMENT", 65, 91], ["the coronavirus", "PROBLEM", 196, 211], ["COVID", "TEST", 297, 302], ["distribution", "OBSERVATION_MODIFIER", 126, 138], ["chain", "OBSERVATION_MODIFIER", 139, 144], ["coronavirus", "OBSERVATION", 200, 211]]], ["As China's exports contracted 17% in January-February compared with last year, global production chains were affected e.g. the European car industry reported shortages of car parts.", [["global production chains", "PROBLEM", 79, 103]]], ["As Chinese ports were closed, Finnish exporters reported that there was shortage of sea containers in the harbors.", [["Chinese ports", "TREATMENT", 3, 16]]], ["It is still very difficult to see how much the supply chain effect explains the weakening of the economic situation in Europe and particularly in Finland.March 2020: A turning point for the Finnish Economy ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDThe sharp decline of the Finnish economy started in March 2020 when GDP contracted by 5.4 % from the previous year.", [["GDP", "CHEMICAL", 326, 329], ["GDP", "CHEMICAL", 326, 329], ["COVID", "TEST", 239, 244], ["The sharp decline", "PROBLEM", 258, 275], ["weakening", "OBSERVATION_MODIFIER", 80, 89], ["economic", "OBSERVATION_MODIFIER", 97, 105], ["sharp", "OBSERVATION_MODIFIER", 262, 267], ["decline", "OBSERVATION_MODIFIER", 268, 275]]], ["According to preliminary figures, the GDP decline was 4.9 % in the second quarter of 2020.", [["GDP", "CHEMICAL", 38, 41], ["GDP", "CHEMICAL", 38, 41], ["GDP", "SIMPLE_CHEMICAL", 38, 41], ["the GDP decline", "TEST", 34, 49]]], ["(37) In addition, official Employment Statistics begun to show a decline in employment and an increase in the number of unemployed persons in March.", [["persons", "ORGANISM", 131, 138], ["persons", "SPECIES", 131, 138], ["a decline", "PROBLEM", 63, 72], ["increase", "OBSERVATION_MODIFIER", 94, 102]]], ["(37)March 2020: A turning point for the Finnish Economy ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDAlthough the official unemployment figures did not capture remarkable change, the number of new spells of furlough increased rapidly in mid-March and the numbers exploded few weeks later.", [["furlough", "DISEASE", 214, 222], ["COVID", "TEST", 89, 94], ["new spells of furlough", "PROBLEM", 200, 222], ["new", "OBSERVATION_MODIFIER", 200, 203], ["spells", "OBSERVATION", 204, 210], ["increased", "OBSERVATION_MODIFIER", 223, 232], ["rapidly", "OBSERVATION_MODIFIER", 233, 240]]], ["Many of the furloughs initiated are already terminated, but the number of furloughed persons was about 136 000 higher at the end of May than it was in February.", [["persons", "ORGANISM", 85, 92], ["persons", "SPECIES", 85, 92]]], ["Since that the number of furloughed persons has declined remarkably, but number of other unemployed persons increased somewhat.", [["persons", "ORGANISM", 36, 43], ["persons", "ORGANISM", 100, 107], ["persons", "SPECIES", 36, 43], ["persons", "SPECIES", 100, 107]]], ["The Finnish furlough system seems to work well in protecting both employees and firms as labor costs are shifted to the Government in this way.", [["labor costs", "PROBLEM", 89, 100]]], ["However, the employment situation remains very fragile, as the Ministry of Employment and Economy reports that 20% of employers have been or are under collaborative consultations for downsizing or reorganization preceding furloughs.", [["very fragile", "PROBLEM", 42, 54]]], ["(38)Leading indicators information is difficult to interpret ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDInformation regarding furloughs and expectations hints that the sharp GDP decline could have ended in the beginning of the third quarter of 2020.", [["GDP", "CHEMICAL", 183, 186], ["GDP", "CHEMICAL", 183, 186], ["GDP", "SIMPLE_CHEMICAL", 183, 186], ["COVID", "TEST", 94, 99], ["the sharp GDP decline", "PROBLEM", 173, 194], ["sharp", "OBSERVATION_MODIFIER", 177, 182]]], ["The consumer confidence index dropped drastically in April and an all-time-low Consumer Confidence Balance was recorded.", [["The consumer confidence index", "TEST", 0, 29]]], ["(41).Leading indicators information is difficult to interpret ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDIn theory, financial markets should mirror expectations.", [["COVID", "TEST", 95, 100]]], ["However, one of the great puzzles of the pandemic is the relatively mild financial market reactions.", [["the relatively mild financial market reactions", "PROBLEM", 53, 99], ["great", "OBSERVATION_MODIFIER", 20, 25], ["pandemic", "OBSERVATION", 41, 49], ["relatively", "OBSERVATION_MODIFIER", 57, 67], ["mild", "OBSERVATION_MODIFIER", 68, 72], ["financial market", "OBSERVATION", 73, 89]]], ["For example, the US stock market has recovered quite well from the initial hit.", [["hit", "OBSERVATION", 75, 78]]], ["The global puzzle is visible in Finland also.", [["global", "OBSERVATION_MODIFIER", 4, 10], ["puzzle", "OBSERVATION", 11, 17], ["visible", "OBSERVATION_MODIFIER", 21, 28]]], ["In the beginning of August, Helsinki OMX25 index was approximately at the same level than it was in early January and about 10 % higher than a year ago.", [["Helsinki OMX25 index", "TEST", 28, 48]]], ["The health of the real economy could be much worse than the indexes indicate.Big Data and other nonconventional statistical information sources ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDAlarming news and the drastic increase in furloughs in late March created a strong demand for economic information.", [["COVID", "TEST", 177, 182], ["the drastic increase in furloughs", "PROBLEM", 214, 247], ["drastic", "OBSERVATION_MODIFIER", 218, 225], ["increase", "OBSERVATION_MODIFIER", 226, 234]]], ["As there is a substantial publishing lag in conventional statistics (e.g. National Accounts), there has been several initiatives to collect, combine and analyze big data and other nonconventional information.", [["substantial", "OBSERVATION_MODIFIER", 14, 25], ["lag", "OBSERVATION_MODIFIER", 37, 40]]], ["(40)Big Data and other nonconventional statistical information sources ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDAlthough nonconventional data sources are difficult to use to predict how large macro aggregates may evolve, they have created important observations (36): The number of entrepreneurs registered as unemployed is tenfold compared to 2019 and their share of all unemployed was 23% at the end of April.", [["COVID", "TEST", 104, 109]]], ["Contrary to the normal situation, new unemployment and furlough spells concentrate onto women, especially young women.", [["women", "ORGANISM", 88, 93], ["women", "ORGANISM", 112, 117], ["women", "SPECIES", 88, 93], ["women", "SPECIES", 112, 117], ["furlough spells", "PROBLEM", 55, 70]]], ["There is less differentiation according education levels and the earnings distribution of those losing their jobs has more middle-income earners than in previous crises.Economic forecasts ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDAs official statistics for the second quarter of 2020 are not yet available and information from leading indicators are confusing, one could argue that economic forecasts published by Finnish authorities, international organizations and various private agencies are perhaps the best guess of the situation at this stage.", [["COVID", "TEST", 221, 226], ["less differentiation", "OBSERVATION_MODIFIER", 9, 29], ["middle", "OBSERVATION_MODIFIER", 123, 129]]], ["However, the usefulness of the published forecasts can be evaluated only afterwards.Economic forecasts ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDThe Finnish Ministry of Finance (MoF) published its Summer Forecast in June (42).", [["COVID", "TEST", 136, 141]]], ["According to the forecast, GDP contracts 6 % in 2020, but returns to normal in 2021.", [["GDP", "CHEMICAL", 27, 30], ["GDP", "SIMPLE_CHEMICAL", 27, 30], ["GDP contracts", "TEST", 27, 40], ["normal", "OBSERVATION", 69, 75]]], ["Unemployment increases from 6.7% in 2019 the 8.5 % in 2020.", [["Unemployment", "DISEASE", 0, 12]]], ["This will deepen General Government deficit by 7 percentage points and turn Public Debt into an increasing trend.", [["an increasing trend", "PROBLEM", 93, 112], ["increasing", "OBSERVATION_MODIFIER", 96, 106], ["trend", "OBSERVATION_MODIFIER", 107, 112]]], ["MoF's forecast is based on the assumption that there is no second wave in the epidemic and restriction can be permanently lifted after three month.", [["no", "UNCERTAINTY", 56, 58]]], ["The OECD has estimated that the extending the restrictions by one month will cost about 2% of GDP as lost output.", [["GDP", "CHEMICAL", 94, 97], ["GDP", "CHEMICAL", 94, 97], ["GDP", "SIMPLE_CHEMICAL", 94, 97]]], ["Accordingly, the effects on the labor market and public finances would be bigger.Economic forecasts ::: THE ECONOMIC CONSEQUENCES OF COVID-19 IN FINLANDAccording to the Bank of Finland's latest forecast (June 9), GDP will contract 7% in 2020 (42).", [["the labor market", "TREATMENT", 28, 44], ["COVID", "TEST", 133, 138], ["GDP", "TEST", 213, 216]]], ["Other forecasts, published by several independent institutions, are as pessimistic as the official ones (43).CONCLUSIONSIn terms of the spread of the COVID-19 pandemic and the number of infected and dead, Finland's coronavirus strategy has so far been successful.", [["coronavirus", "ORGANISM", 215, 226], ["the COVID", "TEST", 146, 155], ["pandemic", "PROBLEM", 159, 167], ["infected and dead", "PROBLEM", 186, 203], ["Finland's coronavirus strategy", "TREATMENT", 205, 235], ["spread", "OBSERVATION_MODIFIER", 136, 142], ["infected", "OBSERVATION", 186, 194]]], ["For instance, in June 2020 it was estimated that if the age-standardized mortality from COVID-19 in Finland had been similar to that in Sweden, Finland would have experienced a number of fatal cases nearly eight times higher than currently.", [["COVID", "TEST", 88, 93]]], ["(44) The success may have been a result of a combination of measures to tackle the outbreak but \u2013 also a matter good luck.", [["the outbreak", "PROBLEM", 79, 91]]], ["The epidemic landed in Finland late compared to many other countries which provided the authorities and politicians time to learn from the experiences from other countries.", [["epidemic", "OBSERVATION_MODIFIER", 4, 12]]], ["It seems that the restrictive measures were put in place early enough and the instructions on physical distancing have been obeyed well.", [["the restrictive measures", "TREATMENT", 14, 38], ["restrictive", "OBSERVATION_MODIFIER", 18, 29]]], ["The local actions by municipalities, hospital districts and regional offices of central government have also been effective.CONCLUSIONSAt the same time, however, the measurement of \u201csuccess\u201d is always relative, because of the unintended consequences of the epidemic control and restrictive measures.", [["the epidemic control", "TREATMENT", 253, 273], ["restrictive measures", "TREATMENT", 278, 298], ["central", "ANATOMY_MODIFIER", 80, 87], ["restrictive", "OBSERVATION_MODIFIER", 278, 289]]], ["At the time of writing the acute pandemic stage is past in most areas of the country \u2013 at least for now \u2013 and it has become clear that many of the precautions taken by health care providers turned out to be slightly too extensive.", [["the acute pandemic stage", "PROBLEM", 23, 47], ["the precautions", "TREATMENT", 143, 158], ["slightly too extensive", "PROBLEM", 207, 229], ["acute", "OBSERVATION_MODIFIER", 27, 32], ["pandemic", "OBSERVATION", 33, 41], ["clear", "OBSERVATION", 124, 129]]], ["It is difficult to say whether scaling back non-urgent care could have been done to lesser extent.", [["non-urgent care", "TREATMENT", 44, 59], ["lesser extent", "OBSERVATION_MODIFIER", 84, 97]]], ["However, what seems certain is that people have refrained from seeking care which may result in increasing unmet care needs and repressed service demand.", [["people", "ORGANISM", 36, 42], ["people", "SPECIES", 36, 42]]], ["This implies a need for careful monitoring and surveillance, and special attention to vulnerable groups such as those people with pre-existing mental health conditions, those with precarious work conditions, recent migrants, children and older people, to name but a few.CONCLUSIONSSome restrictions, such as school closings, most probably have negative impacts on health, wellbeing and the economy, which may have outweighed the benefits of the restrictions.", [["children", "ORGANISM", 225, 233], ["people", "SPECIES", 118, 124], ["children", "SPECIES", 225, 233], ["people", "SPECIES", 244, 250], ["careful monitoring", "TEST", 24, 42], ["surveillance", "TEST", 47, 59], ["pre-existing mental health conditions", "PROBLEM", 130, 167]]], ["However, it is not possible to make far reaching conclusions because the costs and benefits of the restrictions have not been analyzed carefully yet.", [["not possible", "UNCERTAINTY", 15, 27]]], ["A main challenge in analyzing the economic consequences of the pandemic is the difficulty in disentangling the effects of the domestic epidemic and the effects of the policies of the Finnish Government as these took place simultaneously.", [["A main challenge", "TREATMENT", 0, 16], ["the pandemic", "PROBLEM", 59, 71], ["main", "OBSERVATION_MODIFIER", 2, 6], ["challenge", "OBSERVATION_MODIFIER", 7, 16], ["domestic", "OBSERVATION_MODIFIER", 126, 134], ["epidemic", "OBSERVATION", 135, 143]]], ["Available information supports the conclusion that the economic consequences could be drastic in Finland, albeit less dramatic than in large industrial countries, at least in the first phase of pandemic.CONCLUSIONSIn international comparison, the Finnish health system looks highly uniform and is based on local government i.e. municipal financing and organization.", [["pandemic", "PROBLEM", 194, 202], ["drastic", "OBSERVATION_MODIFIER", 86, 93], ["less", "OBSERVATION_MODIFIER", 113, 117], ["dramatic", "OBSERVATION_MODIFIER", 118, 126], ["uniform", "OBSERVATION_MODIFIER", 282, 289]]], ["However, the regional responsibility for public health functions is decentralized and fragmented between municipalities, hospital districts and regional offices of central government.", [["central government", "OBSERVATION", 164, 182]]], ["While so far the decentralized actions have been successful, the steering of the system may prove difficult during more severe crises.", [["more severe crises", "PROBLEM", 115, 133]]], ["For the COVID-19 epidemic, the challenge has materialized in, for instance, purchases of PPE, implementation of testing and providing non acute services for the vulnerable groups.", [["the COVID", "TEST", 4, 13], ["PPE", "PROBLEM", 89, 92], ["testing", "TEST", 112, 119]]], ["This has been successful in most of the municipalities in Finland.", [["successful", "OBSERVATION_MODIFIER", 14, 24]]], ["At the same time, it needs to be highlighted that the health system, in general, has managed to care for the patients with severe COVID-19 infection with good results.CONCLUSIONSIt is possible, even probable, that COVID-19 pandemic has accelerated the development of digital health services and telemedicine in various part of the Finnish healthcare system.", [["infection", "DISEASE", 139, 148], ["patients", "ORGANISM", 109, 117], ["patients", "SPECIES", 109, 117], ["severe COVID-19 infection", "PROBLEM", 123, 148], ["COVID", "TEST", 214, 219], ["telemedicine", "TREATMENT", 295, 307], ["infection", "OBSERVATION", 139, 148]]], ["The Helpline general advice center and moreover the digital self-assessment tool such as Omaolo may have played an important role in providing people self-assessment and potentially prevented unnecessary visits to healthcare facilities.", [["people", "ORGANISM", 143, 149], ["people", "SPECIES", 143, 149]]], ["Based on this development of interoperable infrastructure, it was possible to develop a digital self-assessment COVID-19 online questionnaire service for all free-of-charge.", [["interoperable", "OBSERVATION_MODIFIER", 29, 42], ["infrastructure", "OBSERVATION", 43, 57]]], ["All public and many private healthcare providers refer respiratory infection patients first to the open and accessible online service before any other assessment.", [["respiratory infection", "DISEASE", 55, 76], ["patients", "ORGANISM", 77, 85], ["patients", "SPECIES", 77, 85], ["respiratory infection", "PROBLEM", 55, 76], ["any other assessment", "TEST", 141, 161], ["respiratory", "ANATOMY", 55, 66], ["infection", "OBSERVATION", 67, 76]]], ["The online service is a CE-marked medical device that to specifies the monitoring of COVID-19 epidemic in Finland.CONCLUSIONSThe overall resilience of the Finnish society has been comparatively high, even though the COVID-19 pandemic will have far-reaching systemic effects on the entire society.", [["COVID", "TEST", 85, 90], ["the COVID", "TEST", 212, 221], ["overall", "OBSERVATION_MODIFIER", 129, 136], ["resilience", "OBSERVATION_MODIFIER", 137, 147]]], ["At the time of writing the impact of the pandemic is reflected in changes in the behaviors of the people and many organizations.", [["people", "ORGANISM", 98, 104], ["people", "SPECIES", 98, 104], ["pandemic", "OBSERVATION", 41, 49]]], ["Extensive measures have been taken to help the society to cope with the effects of the pandemic.", [["the pandemic", "PROBLEM", 83, 95]]], ["Opening the society and loosening restrictions step by step are seen as paramount for the economy and for the general wellbeing of Finnish residents.", [["loosening", "OBSERVATION", 24, 33]]], ["However, the effects of loosening the restrictions are yet to be seen.CONCLUSIONSThe number of diagnosed patients in Finland has been so far been rather low compared to the population, suggesting that the lockdown had initiated timely.", [["patients", "ORGANISM", 105, 113], ["patients", "SPECIES", 105, 113], ["loosening the restrictions", "PROBLEM", 24, 50], ["loosening", "OBSERVATION", 24, 33], ["low", "OBSERVATION_MODIFIER", 153, 156]]], ["As the spike in COVID-19 cases had come down the government announced in June that it will follow a \"test, trace, isolate and treat\" strategy also recommended by WHO (1).", [["the spike", "PROBLEM", 3, 12], ["COVID", "TEST", 16, 21], ["a \"test", "TEST", 98, 105]]], ["This can be interpreted as a way of avoiding closing down the society and preventing the second wave to occur through active testing.CONCLUSIONSThe approach has come to a test in early August 2020 when, after the lifting of the restrictions, the reported numbers of diagnosed COVID-19 infections have started to increase indicating the possible start of the second wave of pandemic in Finland.", [["COVID", "DISEASE", 276, 281], ["infections", "DISEASE", 285, 295], ["COVID-19", "ORGANISM", 276, 284], ["active testing", "TEST", 118, 132], ["COVID", "TEST", 276, 281], ["19 infections", "PROBLEM", 282, 295], ["pandemic", "PROBLEM", 373, 381], ["pandemic", "OBSERVATION", 373, 381]]], ["Testing capacity was built up along the way and the large-scale restrictive measures can be seen necessary also in terms of being able to increase testing and treating capacity.", [["Testing capacity", "TEST", 0, 16], ["the large-scale restrictive measures", "TREATMENT", 48, 84], ["testing", "TEST", 147, 154], ["large", "OBSERVATION_MODIFIER", 52, 57], ["restrictive", "OBSERVATION", 64, 75]]], ["It is evaluated that most hospital districts would now have better ability to build up ICU capacity and also evaluate the need for scaling back non-urgent care.", [["scaling back non-urgent care", "TREATMENT", 131, 159]]], ["During the first spike all hospital districts were advised to prioritize COVID-19 care and preparedness which has resulted in long waiting-times to non-urgent care.", [["non-urgent care", "TREATMENT", 148, 163]]], ["The combination of having a large number of patients on waiting lists and a potential second wave may cause substantial problems to the resilience of the Finnish health system.", [["patients", "ORGANISM", 44, 52], ["patients", "SPECIES", 44, 52], ["substantial problems", "PROBLEM", 108, 128], ["large", "OBSERVATION_MODIFIER", 28, 33], ["number", "OBSERVATION_MODIFIER", 34, 40], ["substantial", "OBSERVATION_MODIFIER", 108, 119], ["problems", "OBSERVATION", 120, 128]]], ["The better supplies of protective equipment need to be ensured for possible second wave.", [["protective equipment", "TREATMENT", 23, 43]]], ["The situation is now being remedied through domestic production of protective equipment.CONCLUSIONSThe Finnish legal code has already been amended during COVID-19 pandemic.", [["protective equipment", "TREATMENT", 67, 87], ["COVID", "TEST", 154, 159], ["pandemic", "PROBLEM", 163, 171]]], ["However, the experiences drawn on the first half of 2020 provide important lessons in terms of preparations to potential second wave of coronavirus pandemic and the future epidemics in mind.FundingNo funding was receivedCompeting interestsNone declaredEthical approvalNot requiredUncited References:(33, 39)", [["coronavirus pandemic", "DISEASE", 136, 156], ["coronavirus", "ORGANISM", 136, 147], ["coronavirus pandemic", "PROBLEM", 136, 156]]]], "PMC7262333": [["Koumpouras and Helfgott drafted the article, revised it critically for important intellectual content, and approved the final version to be published.", [["Koumpouras", "TEST", 0, 10]]]], "0b703c00445f6c0bdd40d95f8e9dbd405a3a1e36": [["Coronavirus, including SARS and MERS, has caused two large-scale pandemics in the last two decades 1, 2 .", [["SARS", "DISEASE", 23, 27], ["Coronavirus", "PROBLEM", 0, 11], ["SARS", "PROBLEM", 23, 27], ["large", "OBSERVATION_MODIFIER", 53, 58]]], ["Although viral evasion of host immune responses and virus-induced cytopathic effects are believed to be critical in disease severity, studies from humans who died of SARS and animal models suggested that an excessive and aberrant host cytokine storm resulting in an exuberant immunopathology and lethal disease 9, 10, 11 .", [["SARS", "DISEASE", 166, 170], ["immunopathology", "DISEASE", 276, 291], ["humans", "ORGANISM", 147, 153], ["cytokine", "PROTEIN", 235, 243], ["humans", "SPECIES", 147, 153], ["humans", "SPECIES", 147, 153], ["host immune responses", "PROBLEM", 26, 47], ["virus", "PROBLEM", 52, 57], ["cytopathic effects", "PROBLEM", 66, 84], ["disease severity", "PROBLEM", 116, 132], ["SARS", "PROBLEM", 166, 170], ["an excessive and aberrant host cytokine storm", "PROBLEM", 204, 249], ["an exuberant immunopathology", "PROBLEM", 263, 291], ["lethal disease", "PROBLEM", 296, 310], ["cytopathic", "OBSERVATION_MODIFIER", 66, 76], ["believed to be", "UNCERTAINTY", 89, 103], ["host cytokine storm", "OBSERVATION", 230, 249], ["exuberant", "OBSERVATION_MODIFIER", 266, 275], ["immunopathology", "OBSERVATION", 276, 291]]], ["Inflammatory cytokine storm refers to the immune system gone awry and an excessive inflammatory response flaring out of control.", [["immune system", "ANATOMY", 42, 55], ["cytokine", "PROTEIN", 13, 21], ["Inflammatory cytokine storm", "PROBLEM", 0, 27], ["an excessive inflammatory response flaring", "PROBLEM", 70, 112], ["cytokine storm", "OBSERVATION", 13, 27], ["excessive", "OBSERVATION_MODIFIER", 73, 82], ["inflammatory", "OBSERVATION_MODIFIER", 83, 95], ["response flaring", "OBSERVATION", 96, 112]]], ["Cytokine storms are associated with a wide variety of infectious and noninfectious diseases including graft-versus-host disease, autoimmune disease, severe virus infection, multiple organ dysfunction syndromes and chimeric antigen receptor (CAR)-T cell therapy 12, 13 .", [["graft", "ANATOMY", 102, 107], ["organ", "ANATOMY", 182, 187], ["CAR)-T cell", "ANATOMY", 241, 252], ["graft-versus-host disease", "DISEASE", 102, 127], ["autoimmune disease", "DISEASE", 129, 147], ["infection", "DISEASE", 162, 171], ["multiple organ dysfunction syndromes", "DISEASE", 173, 209], ["Cytokine", "GENE_OR_GENE_PRODUCT", 0, 8], ["graft", "TISSUE", 102, 107], ["organ", "ORGAN", 182, 187], ["chimeric antigen receptor", "GENE_OR_GENE_PRODUCT", 214, 239], ["chimeric antigen receptor", "PROTEIN", 214, 239], ["CAR", "PROTEIN", 241, 244], ["Cytokine storms", "PROBLEM", 0, 15], ["a wide variety of infectious and noninfectious diseases", "PROBLEM", 36, 91], ["graft-versus-host disease", "PROBLEM", 102, 127], ["autoimmune disease", "PROBLEM", 129, 147], ["severe virus infection", "PROBLEM", 149, 171], ["multiple organ dysfunction syndromes", "PROBLEM", 173, 209], ["chimeric antigen receptor (CAR)", "TREATMENT", 214, 245], ["T cell therapy", "TREATMENT", 246, 260], ["infectious", "OBSERVATION", 54, 64], ["noninfectious", "OBSERVATION_MODIFIER", 69, 82], ["graft", "OBSERVATION", 102, 107], ["versus-host disease", "OBSERVATION", 108, 127], ["autoimmune disease", "OBSERVATION", 129, 147], ["severe", "OBSERVATION_MODIFIER", 149, 155], ["virus infection", "OBSERVATION", 156, 171], ["multiple", "OBSERVATION_MODIFIER", 173, 181], ["organ dysfunction", "OBSERVATION", 182, 199]]], ["It has been reported that following SARS-CoV infection, dysregulated cytokine/chemokine responses and higher virus titers cause an inflammatory cytokine storm with lung immunopathological injury 12, 14 .", [["lung", "ANATOMY", 164, 168], ["SARS-CoV infection", "DISEASE", 36, 54], ["SARS-CoV", "ORGANISM", 36, 44], ["lung", "ORGAN", 164, 168], ["cytokine", "PROTEIN", 69, 77], ["chemokine", "PROTEIN", 78, 87], ["inflammatory cytokine", "PROTEIN", 131, 152], ["SARS-CoV", "SPECIES", 36, 44], ["SARS", "PROBLEM", 36, 40], ["CoV infection", "PROBLEM", 41, 54], ["dysregulated cytokine/chemokine responses", "PROBLEM", 56, 97], ["higher virus titers", "PROBLEM", 102, 121], ["an inflammatory cytokine storm", "PROBLEM", 128, 158], ["lung immunopathological injury", "PROBLEM", 164, 194], ["infection", "OBSERVATION", 45, 54], ["inflammatory cytokine storm", "OBSERVATION", 131, 158], ["lung", "ANATOMY", 164, 168], ["immunopathological", "OBSERVATION", 169, 187]]], ["Such Inflammation associated with the cytokine storm may begin at one local site but further spread throughout the body via the systemic circulation 12, 14 .", [["body", "ANATOMY", 115, 119], ["Inflammation", "DISEASE", 5, 17], ["body", "ORGANISM_SUBDIVISION", 115, 119], ["cytokine", "PROTEIN", 38, 46], ["Such Inflammation", "PROBLEM", 0, 17], ["the cytokine storm", "PROBLEM", 34, 52], ["the systemic circulation", "TEST", 124, 148], ["Inflammation", "OBSERVATION", 5, 17], ["cytokine storm", "OBSERVATION", 38, 52], ["body", "ANATOMY_MODIFIER", 115, 119], ["systemic circulation", "ANATOMY", 128, 148]]], ["Similarly, patients infected with SARS-CoV-2, that have been reported recently, have increased plasma concentrations of inflammation related cytokines, including interleukins (IL) 2, 7, and 10, granulocyte-colony stimulating factor (G-CSF), interferon-\uf067-inducible protein 10 (IP10), monocyte chemoattractant protein 1 (MCP1), macrophage inflammatory protein 1 alpha (MIP1A), and tumour necrosis factor \uf061 (TNF-\uf061), especially in moribund patients 15 .", [["plasma", "ANATOMY", 95, 101], ["SARS", "DISEASE", 34, 38], ["inflammation", "DISEASE", 120, 132], ["necrosis", "DISEASE", 386, 394], ["patients", "ORGANISM", 11, 19], ["SARS-CoV-2", "ORGANISM", 34, 44], ["plasma", "ORGANISM_SUBSTANCE", 95, 101], ["interleukins (IL) 2", "GENE_OR_GENE_PRODUCT", 162, 181], ["7", "GENE_OR_GENE_PRODUCT", 183, 184], ["10", "GENE_OR_GENE_PRODUCT", 190, 192], ["granulocyte-colony stimulating factor", "GENE_OR_GENE_PRODUCT", 194, 231], ["G-CSF", "GENE_OR_GENE_PRODUCT", 233, 238], ["interferon-\uf067-inducible protein 10", "GENE_OR_GENE_PRODUCT", 241, 274], ["IP10", "GENE_OR_GENE_PRODUCT", 276, 280], ["monocyte chemoattractant protein 1", "GENE_OR_GENE_PRODUCT", 283, 317], ["MCP1", "GENE_OR_GENE_PRODUCT", 319, 323], ["macrophage inflammatory protein 1 alpha", "GENE_OR_GENE_PRODUCT", 326, 365], ["MIP1A", "GENE_OR_GENE_PRODUCT", 367, 372], ["tumour necrosis factor \uf061", "GENE_OR_GENE_PRODUCT", 379, 403], ["TNF-\uf061", "GENE_OR_GENE_PRODUCT", 405, 410], ["patients", "ORGANISM", 436, 444], ["cytokines", "PROTEIN", 141, 150], ["interleukins (IL) 2, 7, and 10", "PROTEIN", 162, 192], ["granulocyte-colony stimulating factor", "PROTEIN", 194, 231], ["CSF", "PROTEIN", 235, 238], ["interferon-\uf067-inducible protein 10", "PROTEIN", 241, 274], ["IP10", "PROTEIN", 276, 280], ["monocyte chemoattractant protein 1", "PROTEIN", 283, 317], ["MCP1", "PROTEIN", 319, 323], ["macrophage inflammatory protein 1 alpha", "PROTEIN", 326, 365], ["MIP1A", "PROTEIN", 367, 372], ["tumour necrosis factor \uf061", "PROTEIN", 379, 403], ["TNF", "PROTEIN", 405, 408], ["patients", "SPECIES", 11, 19], ["patients", "SPECIES", 436, 444], ["SARS-CoV", "SPECIES", 34, 42], ["SARS", "PROBLEM", 34, 38], ["CoV", "TEST", 39, 42], ["inflammation related cytokines", "PROBLEM", 120, 150], ["interleukins (IL)", "TEST", 162, 179], ["granulocyte", "TEST", 194, 205], ["colony stimulating factor", "TEST", 206, 231], ["G-CSF", "TEST", 233, 238], ["interferon", "TEST", 241, 251], ["inducible protein", "TEST", 254, 271], ["IP10", "TEST", 276, 280], ["monocyte chemoattractant protein", "TEST", 283, 315], ["MCP1", "TEST", 319, 323], ["macrophage inflammatory protein", "TEST", 326, 357], ["alpha", "TEST", 360, 365], ["MIP1A", "TEST", 367, 372], ["tumour necrosis factor", "PROBLEM", 379, 401], ["TNF", "TEST", 405, 408], ["infected", "OBSERVATION", 20, 28], ["increased", "OBSERVATION_MODIFIER", 85, 94], ["plasma concentrations", "OBSERVATION_MODIFIER", 95, 116], ["inflammation", "OBSERVATION", 120, 132], ["granulocyte", "ANATOMY", 194, 205], ["macrophage", "OBSERVATION_MODIFIER", 326, 336], ["inflammatory", "OBSERVATION_MODIFIER", 337, 349], ["tumour necrosis", "OBSERVATION", 379, 394]]], ["Importantly, COVID-19 patients have developed characteristic pulmonary ground glass changes on imaging and peripheral lymphocytes decreasing 14, 16, 17 .", [["pulmonary", "ANATOMY", 61, 70], ["peripheral lymphocytes", "ANATOMY", 107, 129], ["patients", "ORGANISM", 22, 30], ["peripheral lymphocytes", "CELL", 107, 129], ["peripheral lymphocytes", "CELL_TYPE", 107, 129], ["patients", "SPECIES", 22, 30], ["characteristic pulmonary ground glass changes", "PROBLEM", 46, 91], ["imaging", "TEST", 95, 102], ["peripheral lymphocytes", "TEST", 107, 129], ["characteristic", "OBSERVATION_MODIFIER", 46, 60], ["pulmonary", "ANATOMY", 61, 70], ["ground glass changes", "OBSERVATION", 71, 91], ["peripheral", "ANATOMY_MODIFIER", 107, 117], ["lymphocytes", "ANATOMY", 118, 129], ["decreasing", "OBSERVATION_MODIFIER", 130, 140]]], ["More importantly, a large number of inflammatory immune cell infiltrations were also found in a COVID-19 patient with pulmonary pathology 7, 8 .", [["immune cell", "ANATOMY", 49, 60], ["pulmonary", "ANATOMY", 118, 127], ["immune cell", "CELL", 49, 60], ["patient", "ORGANISM", 105, 112], ["pulmonary", "ORGAN", 118, 127], ["patient", "SPECIES", 105, 112], ["inflammatory immune cell infiltrations", "PROBLEM", 36, 74], ["a COVID", "TEST", 94, 101], ["pulmonary pathology", "TEST", 118, 137], ["large", "OBSERVATION_MODIFIER", 20, 25], ["number", "OBSERVATION_MODIFIER", 26, 32], ["inflammatory", "OBSERVATION_MODIFIER", 36, 48], ["immune cell infiltrations", "OBSERVATION", 49, 74], ["pulmonary", "ANATOMY", 118, 127], ["pathology", "OBSERVATION", 128, 137]]], ["These phenomena suggest severe pulmonary inflammation and cytokine storm also exist in SARS-CoV-2 infection.", [["pulmonary", "ANATOMY", 31, 40], ["pulmonary inflammation", "DISEASE", 31, 53], ["SARS-CoV-2 infection", "DISEASE", 87, 107], ["pulmonary", "ORGAN", 31, 40], ["SARS-CoV-2", "ORGANISM", 87, 97], ["cytokine", "PROTEIN", 58, 66], ["SARS-CoV-2", "SPECIES", 87, 97], ["These phenomena", "PROBLEM", 0, 15], ["severe pulmonary inflammation", "PROBLEM", 24, 53], ["cytokine storm", "PROBLEM", 58, 72], ["SARS", "PROBLEM", 87, 91], ["CoV-2 infection", "PROBLEM", 92, 107], ["suggest", "UNCERTAINTY", 16, 23], ["severe", "OBSERVATION_MODIFIER", 24, 30], ["pulmonary", "ANATOMY", 31, 40], ["inflammation", "OBSERVATION", 41, 53], ["cytokine storm", "OBSERVATION", 58, 72], ["SARS", "OBSERVATION", 87, 91], ["CoV", "OBSERVATION_MODIFIER", 92, 95], ["infection", "OBSERVATION", 98, 107]]], ["At present, symptomatic treatments with organ support to moribund patients are the mainstays of clinical managements 17 .", [["organ", "ANATOMY", 40, 45], ["organ", "ORGAN", 40, 45], ["patients", "ORGANISM", 66, 74], ["patients", "SPECIES", 66, 74], ["symptomatic treatments", "TREATMENT", 12, 34], ["organ support", "TREATMENT", 40, 53], ["clinical managements", "TREATMENT", 96, 116], ["symptomatic", "OBSERVATION_MODIFIER", 12, 23]]], ["It is urgent to identify the immunopathology mechanism to delay the pulmonary immune injury.", [["pulmonary", "ANATOMY", 68, 77], ["pulmonary immune injury", "DISEASE", 68, 91], ["pulmonary", "ORGAN", 68, 77], ["the pulmonary immune injury", "PROBLEM", 64, 91], ["pulmonary", "ANATOMY", 68, 77], ["immune injury", "OBSERVATION", 78, 91]]]], "78974fc5a98da4e4cb2368ad42d224ae750520b6": [["IntroductionOutbreaks of the infectious coronavirus disease of 2019 (COVID -19) have been reported worldwide [1, 2] .", [["infectious coronavirus disease", "DISEASE", 29, 59], ["coronavirus", "SPECIES", 40, 51], ["the infectious coronavirus disease", "PROBLEM", 25, 59], ["COVID", "TEST", 69, 74], ["infectious", "OBSERVATION_MODIFIER", 29, 39]]], ["In response, numerous studies on COVID-19 have been conducted on different aspects, including disease prevention, control, diagnosis, causes, and epidemiology [3] .", [["numerous studies", "TEST", 13, 29], ["COVID", "TEST", 33, 38], ["disease prevention", "TREATMENT", 94, 112]]], ["During this state of emergency, people voluntarily self-isolated and no government-enforced lockdown of the prefectures (districts) was implemented.IntroductionMany epidemic modeling approaches exist [4] and various mathematical models have been used to demonstrate different aspects related to COVID-19, including serial intervals [5] , transmission in China [6] , and case studies in Wuhan, China [7] , Italy [8] , and Spain [9] .", [["people", "ORGANISM", 32, 38], ["people", "SPECIES", 32, 38], ["various mathematical models", "TREATMENT", 208, 235], ["COVID", "TEST", 295, 300]]], ["Comparisons among different countries have also been made [10] and the importance of different models in developing policies has * Kanagawa, Saitama, and Chiba are considered adjacent prefectures of Tokyo. ** Gifu is considered an adjacent prefecture of Aichi. *** Hyogo, Kyoto, and Shiga are considered adjacent prefectures of Osaka. **** Saga is considered an adjacent prefecture of Fukuoka.IntroductionEnvironmental co-factors potentially influencing COVID-19 morbidity, including ambient temperature, absolute humidity, and air pollution, have been studied [15] [16] [17] [18] [19] [20] [21] [22] .", [["[15] [16] [17] [18] [19] [20] [21] [22]", "CHEMICAL", 561, 600], ["Osaka", "ORGANISM", 328, 333], ["[15] [16] [17] [18] [19] [20] [21] [22]", "SIMPLE_CHEMICAL", 561, 600], ["COVID", "TEST", 454, 459], ["ambient temperature", "TEST", 484, 503], ["absolute humidity", "PROBLEM", 505, 522], ["air pollution", "PROBLEM", 528, 541], ["Aichi", "OBSERVATION", 254, 259], ["air pollution", "OBSERVATION", 528, 541]]], ["However, neither these studies nor the above-mentioned modeling studies have considered the impact of population density and ambient conditions on both the spread and decay duration [23] .", [["these studies", "TEST", 17, 30], ["modeling studies", "TEST", 55, 71], ["population density", "PROBLEM", 102, 120], ["ambient conditions", "PROBLEM", 125, 143], ["population", "OBSERVATION_MODIFIER", 102, 112], ["density", "OBSERVATION", 113, 120]]], ["The necessity of population density scaling in epidemic transmission models has been suggested for infectious diseases in general [24] , indicating that the factors characterizing the spread and decay durations might be different.", [["infectious diseases", "DISEASE", 99, 118], ["population density scaling", "PROBLEM", 17, 43], ["infectious diseases", "PROBLEM", 99, 118], ["population", "OBSERVATION_MODIFIER", 17, 27], ["density", "OBSERVATION_MODIFIER", 28, 35], ["scaling", "OBSERVATION_MODIFIER", 36, 43]]], ["Recent studies have confirmed the effect of temperature and relative humidity on morbidity rates in Brazil [22, 25] and the morbidity/mortality rates in Japan [26] .", [["Recent studies", "TEST", 0, 14], ["temperature", "TEST", 44, 55], ["morbidity rates", "TEST", 81, 96], ["mortality rates", "TEST", 134, 149]]], ["Studies with wider scopes include global data analysis-discussion on how temperature and humidity are correlated with the infection and fatality rates of the COVID-19 pandemic [27, 28] .", [["infection", "DISEASE", 122, 131], ["wider scopes", "TEST", 13, 25], ["global data analysis", "TEST", 34, 54], ["the infection", "PROBLEM", 118, 131], ["the COVID", "TEST", 154, 163], ["infection", "OBSERVATION", 122, 131]]], ["Both studies focus on the morbidity and mortality rates in their respective study area and globally, but neither of them discusses the effect of environmental factors on the duration of COVID-19, which is an essential factor for policymaking.", [["Both studies", "TEST", 0, 12], ["mortality rates", "TEST", 40, 55], ["COVID", "TEST", 186, 191]]], ["Its effect on the mortality and morbidity rates is still controversial; for example, no correlation with weather data was found in a study of 122 cities in China [19] , whereas a correlation was reported in [15] .", [["morbidity rates", "TEST", 32, 47], ["weather data", "TEST", 105, 117], ["a study", "TEST", 131, 138], ["effect", "OBSERVATION_MODIFIER", 4, 10]]], ["A report highlighting the duration of the pandemic spread may lead to better management of medical resources and protective gear, which is a well-known life-threatening factor during the evolution of COVID-19.IntroductionIn this study, we evaluate the effect of different ambient conditions and population densities on the spread and decay durations of COVID-19 in different prefectures of Japan.", [["pandemic", "DISEASE", 42, 50], ["COVID-19", "CHEMICAL", 353, 361], ["the pandemic spread", "PROBLEM", 38, 57], ["COVID", "TEST", 200, 205], ["this study", "TEST", 224, 234], ["different ambient conditions", "TREATMENT", 262, 290], ["population densities", "PROBLEM", 295, 315], ["COVID", "TEST", 353, 358], ["population", "OBSERVATION_MODIFIER", 295, 305], ["densities", "OBSERVATION", 306, 315]]], ["To the best of our knowledge, this is the first study to discuss the effect of environmental factors during COVID-19 in Japan.", [["the first study", "TEST", 38, 53], ["COVID", "TEST", 108, 113]]], ["Japan provides an interesting case study for environmental factors, because medical services and social reactions are similar nationwide and high-quality data were properly recorded.Data SourceThree datasets were utilized in this study.", [["this study", "TEST", 225, 235]]], ["The first dataset contains the number of confirmed positive cases in each prefecture that was obtained from Toyo Keizai Online [29] and is based on a report by the Ministry of Health, Labour and Welfare [30] .Data SourceBecause the state of emergency was terminated on 25 May 2020, this study utilized data from 15 March 2020, to that date.", [["this study", "TEST", 282, 292]]], ["COVID-19 started spreading in mid-February in the Aichi Prefecture, which is the only prefecture where the spread started earlier than 15 March.", [["COVID-19", "CHEMICAL", 0, 8], ["COVID", "TEST", 0, 5]]], ["As such, additional data were obtained from the Aichi Prefecture website [31] and included in this study.Data SourceThe second dataset consists of population and prefecture area data that were obtained from the Statistics Bureau of Japan [32] (Table 1) .", [["additional data", "TEST", 9, 24], ["this study", "TEST", 94, 104], ["prefecture area data", "TEST", 162, 182]]], ["In adjacent prefectures, several people were found to commute to the primary prefectures, thus potentially affecting the prefecture data, and should, therefore, not be neglected.Data SourceThe third dataset contains weather data obtained from the Japan Meteorological Agency for each prefecture during the time of the pandemic.", [["people", "ORGANISM", 33, 39], ["people", "SPECIES", 33, 39], ["weather data", "TEST", 216, 228], ["the pandemic", "PROBLEM", 314, 326]]], ["The absolute humidity was derived from the relative humidity and ambient temperature data [33] .Data ProcessingThe number of confirmed positive tests may be influenced by diagnostic data, based on Japanese guidelines, serial intervals, and latency, which is affected by each doctor's judgment; therefore, the moving average over 7 days (\u00b1 3 days in addition to the corresponding day) was considered to reduce the effect of potential singularities.", [["The absolute humidity", "TREATMENT", 0, 21], ["ambient temperature data", "TEST", 65, 89], ["positive tests", "TEST", 135, 149], ["diagnostic data", "TEST", 171, 186], ["serial intervals", "TEST", 218, 234], ["potential singularities", "PROBLEM", 423, 446], ["absolute humidity", "OBSERVATION", 4, 21], ["positive", "OBSERVATION", 135, 143], ["potential singularities", "OBSERVATION", 423, 446]]], ["This duration was used in the trajectory analysis of COVID-19 as well [34] , also considering its incubation time (mean value of 5.1 days) [35] .", [["COVID", "TEST", 53, 58]]], ["Additional small peaks were still observed, which were attributed to clusters of patients (e.g., nosocomial infections, nursing home patients, and people returning from foreign countries).", [["nosocomial infections", "DISEASE", 97, 118], ["patients", "ORGANISM", 81, 89], ["patients", "ORGANISM", 133, 141], ["people", "ORGANISM", 147, 153], ["patients", "SPECIES", 81, 89], ["patients", "SPECIES", 133, 141], ["people", "SPECIES", 147, 153], ["Additional small peaks", "PROBLEM", 0, 22], ["nosocomial infections", "PROBLEM", 97, 118], ["small", "OBSERVATION_MODIFIER", 11, 16], ["peaks", "OBSERVATION", 17, 22]]], ["Similar to other countries, the number of confirmed positives may depend on the day of the week (see [34] ); in general, the number of tests conducted on weekends is lower than on weekdays.Data ProcessingThis tendency prevents the direct fitting of the observed cases for comparison with a computational model (typically expressed as a bell-shape or a log-normal distribution, similar to the trend in theoretical models [36, 37] ).", [["normal distribution", "OBSERVATION_MODIFIER", 356, 375]]], ["Therefore, our study introduces the criteria of days required for spreading from 10% to 90% and for decaying from 90% to 10% of the peak [38] of the confirmed positives (7-day average [34] ), as metrics for the evaluation, as shown in Figure 1a .", [["our study", "TEST", 11, 20], ["the peak", "TEST", 128, 136], ["the evaluation", "TEST", 207, 221]]], ["A limitation of this metric is that a certain minimum number of samples is needed because if the number of samples is small, one or two new patients would significantly influence the results.", [["patients", "ORGANISM", 140, 148], ["patients", "SPECIES", 140, 148], ["small", "OBSERVATION_MODIFIER", 118, 123]]], ["Therefore, as a pre-processing step, prefecture data were excluded if the daily maximum number of confirmed positive cases was less than 10.", [["a pre-processing step", "TEST", 14, 35], ["prefecture data", "TEST", 37, 52], ["positive cases", "TEST", 108, 122]]], ["In addition, the percentage of morbidity/mortality in nosocomial infections and nursing home patients should not be significant.", [["nosocomial infections", "DISEASE", 54, 75], ["patients", "ORGANISM", 93, 101], ["patients", "SPECIES", 93, 101], ["morbidity", "PROBLEM", 31, 40], ["nosocomial infections", "PROBLEM", 54, 75], ["morbidity", "OBSERVATION", 31, 40], ["nosocomial", "OBSERVATION_MODIFIER", 54, 64], ["infections", "OBSERVATION", 65, 75]]], ["In Ishikawa, however, 75% of the confirmed deaths were nosocomial infections.", [["deaths", "DISEASE", 43, 49], ["nosocomial infections", "DISEASE", 55, 76], ["nosocomial infections", "PROBLEM", 55, 76], ["nosocomial", "OBSERVATION_MODIFIER", 55, 65], ["infections", "OBSERVATION", 66, 76]]], ["Two prefectures (Saitama and Shiga) were excluded from the analysis due to a lack of humidity data, which are essential for discussing the effect of ambient conditions on the spread and decay durations (see the data source in the next subsection).", [["Two prefectures (Saitama and Shiga)", "PROBLEM", 0, 35], ["the analysis", "TEST", 55, 67], ["ambient conditions", "TREATMENT", 149, 167]]], ["Based on this criterion, 16 prefectures met the minimum number of confirmed positive cases, as shown in Figure 1bStatisticsA statistical analysis was conducted to determine the correlation between different factors and both the spread and decay periods of the pandemic using the software JMP (SAS Institute, Cary, NC, USA).", [["this criterion", "TEST", 9, 23], ["A statistical analysis", "TEST", 123, 145]]], ["Subsequently, a multivariate analysis using linear regression was conducted using the same software.", [["a multivariate analysis", "TEST", 14, 37], ["linear regression", "TREATMENT", 44, 61]]], ["Figure 2 shows the time-series of the confirmed new positive cases for the spread and decay durations based on the data presented in Table 2 .ResultsAs shown in Figure 2a , the number of normalized confirmed cases increased in most prefectures, and multiple peaks are observed in some prefectures.", [["new positive cases", "PROBLEM", 48, 66], ["the data", "TEST", 111, 119], ["multiple peaks", "PROBLEM", 249, 263], ["increased", "OBSERVATION_MODIFIER", 214, 223], ["multiple", "OBSERVATION_MODIFIER", 249, 257], ["peaks", "OBSERVATION", 258, 263]]], ["In Aichi, the start of the spread period, TSS, was three weeks earlier than in the other studied prefectures (Table 2) , and in mid-March, when traveling residents returned home from foreign countries in response to a call from the Japanese government, two large peaks are visible in the spread graph.", [["two large peaks", "PROBLEM", 253, 268], ["large", "OBSERVATION_MODIFIER", 257, 262], ["peaks", "OBSERVATION", 263, 268], ["visible", "OBSERVATION_MODIFIER", 273, 280]]], ["A similar tendency is observed in Saga, while in Chiba, and Gifu, only small peaks are observed.StatisticsA statistical analysis was conducted to determine the correlation between different factors and both the spread and decay periods of the pandemic using the software JMP (SAS Institute, Cary, NC, USA).", [["A similar tendency", "PROBLEM", 0, 18], ["small peaks", "PROBLEM", 71, 82], ["StatisticsA statistical analysis", "TEST", 96, 128], ["similar", "OBSERVATION_MODIFIER", 2, 9], ["tendency", "OBSERVATION", 10, 18], ["small", "OBSERVATION_MODIFIER", 71, 76], ["peaks", "OBSERVATION", 77, 82]]], ["Subsequently, a multivariate analysis using linear regression was conducted using the same software.", [["a multivariate analysis", "TEST", 14, 37], ["linear regression", "TREATMENT", 44, 61]]], ["Figure 2 shows the time-series of the confirmed new positive cases for the spread and decay durations based on the data presented in Table 2 .", [["new positive cases", "PROBLEM", 48, 66]]], ["Starting and terminating dates of the spread and decay stages of the COVID-19 pandemic and the date (year 2020) when the highest daily peak value of confirmed cases was reported.", [["the COVID", "TEST", 65, 74]]], ["As shown in Figure 2a , the number of normalized confirmed cases increased in most prefectures, and multiple peaks are observed in some prefectures.", [["multiple peaks", "PROBLEM", 100, 114], ["increased", "OBSERVATION_MODIFIER", 65, 74], ["multiple", "OBSERVATION_MODIFIER", 100, 108], ["peaks", "OBSERVATION", 109, 114]]], ["In Aichi, the start of the spread period, T SS , was three weeks earlier than in the other studied prefectures (Table 2) , and in mid-March, when traveling residents returned home from foreign countries in response to a call from the Japanese government, two large peaks are visible in the spread graph.", [["two large peaks", "PROBLEM", 255, 270], ["large", "OBSERVATION_MODIFIER", 259, 264], ["peaks", "OBSERVATION", 265, 270]]], ["A similar tendency is observed in Saga, while in Chiba, and Gifu, only small peaks are observed.ResultsAs shown in Figure 2b , which illustrates the pandemic decay timeline, the number of normalized confirmed cases decreased over time in most prefectures.", [["A similar tendency", "PROBLEM", 0, 18], ["small peaks", "PROBLEM", 71, 82], ["ResultsAs", "TEST", 96, 105], ["similar", "OBSERVATION_MODIFIER", 2, 9], ["tendency", "OBSERVATION", 10, 18], ["small", "OBSERVATION_MODIFIER", 71, 76], ["peaks", "OBSERVATION", 77, 82], ["decreased", "OBSERVATION_MODIFIER", 215, 224]]], ["Similar to Figure 2a , multiple peaks are observed in some prefectures, including Kanagawa and Hyogo.", [["multiple", "OBSERVATION_MODIFIER", 23, 31], ["peaks", "OBSERVATION", 32, 37]]], ["These relationships are separated into two groups based on hierarchical clustering.", [["hierarchical clustering", "OBSERVATION", 59, 82]]], ["The red group consists of metropolitan regions with a relatively high population density compared to the more rural blue group.", [["a relatively high population density", "PROBLEM", 52, 88], ["red", "OBSERVATION", 4, 7], ["metropolitan", "ANATOMY_MODIFIER", 26, 38], ["relatively", "OBSERVATION_MODIFIER", 54, 64], ["high", "OBSERVATION_MODIFIER", 65, 69], ["population", "OBSERVATION_MODIFIER", 70, 80], ["density", "OBSERVATION", 81, 88]]], ["Based on Figure 3 , we hypothesize that population density is an important factor, and further investigation is required.", [["further investigation", "TEST", 87, 108], ["population", "OBSERVATION_MODIFIER", 40, 50], ["density", "OBSERVATION", 51, 58]]], ["For environmental factors, the mean daily temperature and humidity values listed in Table 3 were obtained for the two durations listed in Table 2 .", [["environmental factors", "PROBLEM", 4, 25], ["the mean daily temperature", "TEST", 27, 53], ["humidity values", "TEST", 58, 73]]], ["Figure 5 shows the effect of the ambient parameters on the spread and decay durations.", [["the ambient parameters", "TREATMENT", 29, 51]]], ["The daily mean, maximum, and diurnal change values were selected based on previous studies on the influenza virus [40, 41] and suggest that the temperature and humidity variations are likely correlated with the COVID-19 mortality rate [15] .", [["influenza", "DISEASE", 98, 107], ["influenza virus", "ORGANISM", 98, 113], ["diurnal change values", "PROBLEM", 29, 50], ["previous studies", "TEST", 74, 90], ["the influenza virus", "PROBLEM", 94, 113], ["the temperature and humidity variations", "PROBLEM", 140, 179], ["the COVID", "TEST", 207, 216], ["mortality rate", "TEST", 220, 234]]], ["As seen in Figure 5 , such a correlation was observed for the data analyzed in this study.", [["the data", "TEST", 58, 66], ["this study", "TEST", 79, 89]]], ["If the adjacent prefectures and those prefectures with multiple peaks in the curves are excluded, a mild correlation is observed for the maximum absolute humidity (R 2 > 0.2) with the spread and decay durations (see also Table 4 ).", [["the adjacent prefectures and those prefectures with multiple peaks in the curves", "PROBLEM", 3, 83], ["the maximum absolute humidity", "TEST", 133, 162], ["multiple", "OBSERVATION_MODIFIER", 55, 63], ["peaks", "OBSERVATION", 64, 69], ["mild", "OBSERVATION_MODIFIER", 100, 104]]], ["In both cases, including and excluding adjacent prefectures, the maximum absolute humidity is the parameter that correlates significantly with duration.", [["the maximum absolute humidity", "TEST", 61, 90], ["maximum", "OBSERVATION_MODIFIER", 65, 72], ["absolute humidity", "OBSERVATION", 73, 90]]], ["A brief discussion on how maximum ambient temperature and maximum absolute humidity are correlated can be found in Appendix A. Figure 4 shows the relationship between the spread and decay durations (DS and DD) and the population density.", [["how maximum ambient temperature", "TREATMENT", 22, 53], ["maximum absolute humidity", "TREATMENT", 58, 83], ["the population density", "PROBLEM", 214, 236], ["Appendix", "ANATOMY", 115, 123], ["population", "OBSERVATION_MODIFIER", 218, 228], ["density", "OBSERVATION", 229, 236]]], ["The data of Aichi and Saga prefectures were excluded due to their outlier status.", [["Aichi", "PROBLEM", 12, 17]]], ["The resulting curves confirm the correlation between the spread and decay durations and the population density.", [["The resulting curves", "TEST", 0, 20], ["the population density", "PROBLEM", 88, 110], ["population", "OBSERVATION_MODIFIER", 92, 102], ["density", "OBSERVATION", 103, 110]]], ["For environmental factors, the mean daily temperature and humidity values listed in Table 3 were obtained for the two durations listed in Table 2 .", [["environmental factors", "PROBLEM", 4, 25], ["the mean daily temperature", "TEST", 27, 53], ["humidity values", "TEST", 58, 73]]], ["Figure 5 shows the effect of the ambient parameters on the spread and decay durations.", [["the ambient parameters", "TREATMENT", 29, 51]]], ["The daily mean, maximum, and diurnal change values were selected based on previous studies on the influenza virus [40, 41] and suggest that the temperature and humidity variations are likely correlated with the COVID-19 mortality rate [15] .", [["influenza", "DISEASE", 98, 107], ["influenza virus", "ORGANISM", 98, 113], ["diurnal change values", "PROBLEM", 29, 50], ["previous studies", "TEST", 74, 90], ["the influenza virus", "PROBLEM", 94, 113], ["the temperature and humidity variations", "PROBLEM", 140, 179], ["the COVID", "TEST", 207, 216], ["mortality rate", "TEST", 220, 234]]], ["As seen in Figure 5 , such a correlation was observed for the data analyzed in this study.", [["the data", "TEST", 58, 66], ["this study", "TEST", 79, 89]]], ["If the adjacent prefectures and those prefectures with multiple peaks in the curves are excluded, a mild correlation is observed for the maximum absolute humidity (R 2 > 0.2) with the spread and decay durations (see also Table 4 ).", [["the adjacent prefectures and those prefectures with multiple peaks in the curves", "PROBLEM", 3, 83], ["the maximum absolute humidity", "TEST", 133, 162], ["multiple", "OBSERVATION_MODIFIER", 55, 63], ["peaks", "OBSERVATION", 64, 69], ["mild", "OBSERVATION_MODIFIER", 100, 104]]], ["In both cases, including and excluding adjacent prefectures, the maximum absolute humidity is the parameter that correlates significantly with duration.", [["the maximum absolute humidity", "TEST", 61, 90], ["maximum", "OBSERVATION_MODIFIER", 65, 72], ["absolute humidity", "OBSERVATION", 73, 90]]], ["A brief discussion on how maximum ambient temperature and maximum absolute humidity are correlated can be found in Appendix A. A multivariate correlation analysis was conducted to examine the relationship between the daily maximum temperature and absolute humidity values measured during the study period (pandemic spread and decay) and the population density ( Figure 6 ).", [["how maximum ambient temperature", "TREATMENT", 22, 53], ["maximum absolute humidity", "TREATMENT", 58, 83], ["A multivariate correlation analysis", "TEST", 127, 162], ["absolute humidity values", "TEST", 247, 271], ["the study", "TEST", 288, 297], ["Appendix", "ANATOMY", 115, 123], ["population", "OBSERVATION_MODIFIER", 341, 351], ["density", "OBSERVATION", 352, 359]]], ["The data of Aichi and Saga prefectures were excluded due to their outlier status.", [["Aichi", "PROBLEM", 12, 17]]], ["The results yield adjusted R 2 values of 0.53 (p < 0.05) and 0.24 (p = 0.130) in the spread and decay stages, respectively, indicating variability within some prefectures, A multivariate correlation analysis was conducted to examine the relationship between the daily maximum temperature and absolute humidity values measured during the study period (pandemic spread and decay) and the population density ( Figure 6 ).", [["A multivariate correlation analysis", "TEST", 172, 207], ["absolute humidity values", "TEST", 292, 316], ["the study", "TEST", 333, 342], ["variability", "OBSERVATION_MODIFIER", 135, 146], ["population", "OBSERVATION_MODIFIER", 386, 396], ["density", "OBSERVATION", 397, 404]]], ["The data of Aichi and Saga prefectures were excluded due to their outlier status.", [["Aichi", "PROBLEM", 12, 17]]], ["The results yield adjusted R 2 values of 0.53(p < 0.05) and 0.24(p = 0.130) in the spread and decay stages, respectively, indicating variability within some prefectures, as shown in Table 5 .", [["variability", "OBSERVATION_MODIFIER", 133, 144]]], ["The standardized partial regression coefficients of population density, daily maximum temperature, and absolute humidity are 0.611, 0.203, and \u22120.682, respectively, for the spread duration, while they are 0.388, 0.544, and \u22120.219, respectively, for the decay duration ( Figure 6 ).DiscussionThe effect of temperature and humidity on morbidity and mortality has long been investigated in research on health problems caused by different environmental factors (e.g., [42, 43] ).", [["The standardized partial regression coefficients of population density", "PROBLEM", 0, 70], ["maximum temperature", "TEST", 78, 97], ["absolute humidity", "TEST", 103, 120], ["morbidity", "TREATMENT", 333, 342], ["partial", "OBSERVATION_MODIFIER", 17, 24], ["regression", "OBSERVATION_MODIFIER", 25, 35], ["coefficients", "OBSERVATION_MODIFIER", 36, 48], ["population", "OBSERVATION_MODIFIER", 52, 62], ["density", "OBSERVATION", 63, 70], ["absolute", "OBSERVATION_MODIFIER", 103, 111], ["humidity", "OBSERVATION_MODIFIER", 112, 120]]], ["Even for COVID-19, as reviewed in the introduction, their influence has been discussed extensively in different countries.", [["COVID", "TEST", 9, 14]]], ["A case study of COVID-19 in Japan highlights the environmental factors in view of the consistency of data recording, healthcare quality, and social response to the outbreak of the disease.", [["A case study", "TEST", 0, 12], ["COVID", "TEST", 16, 21], ["the disease", "PROBLEM", 176, 187], ["disease", "OBSERVATION", 180, 187]]], ["The limitation of data, which is partly attributable to different policies in Japan, as in Section 2, is one factor hampering the analysis of available COVID-19 data.", [["available COVID", "TEST", 142, 157]]], ["A further challenge is the large variation in data reliability, consistency, and uniformity.DiscussionIn this study, the durations of the spread and decay stages were evaluated, for the first time, to assist with the setting of policies and action plans.", [["A further challenge", "TREATMENT", 0, 19], ["this study", "TEST", 105, 115], ["large", "OBSERVATION_MODIFIER", 27, 32], ["variation", "OBSERVATION_MODIFIER", 33, 42], ["uniformity", "OBSERVATION_MODIFIER", 81, 91]]], ["Although the results obtained in this study cannot be directly implemented in all cases, it provides valuable insight into how environmental factors influence the transmission phase during a pandemic in a more general framework.DiscussionThe effect of temperature and humidity on morbidity and mortality has long been investigated in research on health problems caused by different environmental factors (e.g., [42, 43] ).", [["this study", "TEST", 33, 43], ["morbidity", "TREATMENT", 280, 289]]], ["Even for COVID-19, as reviewed in the introduction, their influence has been discussed extensively in different countries.", [["COVID", "TEST", 9, 14]]], ["A case study of COVID-19 in Japan highlights the environmental factors in view of the consistency of data recording, healthcare quality, and social response to the outbreak of the disease.", [["A case study", "TEST", 0, 12], ["COVID", "TEST", 16, 21], ["the disease", "PROBLEM", 176, 187], ["disease", "OBSERVATION", 180, 187]]], ["The limitation of data, which is partly attributable to different policies in Japan, as in Section 2, is one factor hampering the analysis of available COVID-19 data.", [["available COVID", "TEST", 142, 157]]], ["A further challenge is the large variation in data reliability, consistency, and uniformity.DiscussionIn this study, the durations of the spread and decay stages were evaluated, for the first time, to assist with the setting of policies and action plans.", [["A further challenge", "TREATMENT", 0, 19], ["this study", "TEST", 105, 115], ["large", "OBSERVATION_MODIFIER", 27, 32], ["variation", "OBSERVATION_MODIFIER", 33, 42], ["uniformity", "OBSERVATION_MODIFIER", 81, 91]]], ["Although the results obtained in this study cannot be directly implemented in all cases, it provides valuable insight into how environmental factors influence the transmission phase during a pandemic in a more general framework.DiscussionThe COVID-19 spread and decay durations of 16 prefectures in Japan that had a daily maximum of confirmed positive cases exceeding 10 were compared.", [["COVID-19", "DNA", 242, 250], ["this study", "TEST", 33, 43], ["The COVID", "TEST", 238, 247]]], ["One difficulty in handling the data was the lower number of cases in Japan compared to most other countries; for example, the number is one to two orders of magnitude smaller than that of most European countries (e.g., see [34] ).", [["difficulty", "OBSERVATION", 4, 14]]], ["As mentioned above, a time-series analysis of COVID-19 cases in Japan is not feasible due to the Japanese COVID-19 policy combined with the incubation period.DiscussionThe results of this study show that the number of confirmed cases generally increased and then decreased, forming bell-shaped or log-normal curves [36, 37] .", [["COVID", "TEST", 46, 51], ["the Japanese COVID", "TEST", 93, 111], ["this study", "TEST", 183, 193], ["increased", "OBSERVATION_MODIFIER", 244, 253], ["decreased", "OBSERVATION_MODIFIER", 263, 272], ["shaped", "OBSERVATION_MODIFIER", 287, 293]]], ["However, significant dual peaks are observed in Aichi and Saga during the spread stage and in Aichi, Saga and Tokyo during the decay stage.", [["significant dual peaks", "PROBLEM", 9, 31], ["significant", "OBSERVATION_MODIFIER", 9, 20], ["dual peaks", "OBSERVATION", 21, 31]]], ["According to reports of each prefecture, this is mainly caused by patient clusters, which are attributed to nosocomial infections, nursing home patients, and travelers returning from foreign countries.", [["nosocomial infections", "DISEASE", 108, 129], ["patient", "ORGANISM", 66, 73], ["patients", "ORGANISM", 144, 152], ["patient", "SPECIES", 66, 73], ["patients", "SPECIES", 144, 152], ["nosocomial infections", "PROBLEM", 108, 129], ["attributed to", "UNCERTAINTY", 94, 107], ["nosocomial", "OBSERVATION_MODIFIER", 108, 118], ["infections", "OBSERVATION", 119, 129]]], ["The duration of such peaks is relatively short compared to the prefecture durations and generally shorter than the estimated ones.", [["such peaks", "PROBLEM", 16, 26], ["peaks", "OBSERVATION_MODIFIER", 21, 26], ["relatively", "OBSERVATION_MODIFIER", 30, 40], ["short", "OBSERVATION_MODIFIER", 41, 46]]], ["The total spread and decay durations in Aichi were shorter than 20 days for the first bell-shaped curve, whereas the estimated duration from the multivariate analysis was 35 days and thus may not be considered as a second outbreak.", [["Aichi", "ORGANISM", 40, 45], ["the multivariate analysis", "TEST", 141, 166], ["total", "OBSERVATION_MODIFIER", 4, 9], ["spread", "OBSERVATION_MODIFIER", 10, 16], ["may not be considered", "UNCERTAINTY", 188, 209]]], ["If the duration defining threshold is changed (e.g., 0.05. to 0.95), the tendency does not change for distributions following a bell-shape and the duration increases by 30%.", [["a bell-shape", "TEST", 126, 138]]], ["However, some differences are apparent in prefectures where small peaks (i.e., cluster infections) are observed.", [["infections", "DISEASE", 87, 97], ["small peaks", "PROBLEM", 60, 71], ["cluster infections", "PROBLEM", 79, 97], ["some", "OBSERVATION_MODIFIER", 9, 13], ["differences", "OBSERVATION_MODIFIER", 14, 25], ["small", "OBSERVATION_MODIFIER", 60, 65], ["peaks", "OBSERVATION_MODIFIER", 66, 71], ["cluster", "OBSERVATION_MODIFIER", 79, 86], ["infections", "OBSERVATION", 87, 97]]], ["In general, such prefectures have been excluded or treated separately, thus not influencing our conclusions.DiscussionMost noteworthy is the evaluation of the effect of population density on the spread and decay durations.", [["the evaluation", "TEST", 137, 151], ["population density", "PROBLEM", 169, 187], ["population", "OBSERVATION_MODIFIER", 169, 179], ["density", "OBSERVATION", 180, 187]]], ["The results for the primary prefectures show a good correlation between these parameters, indicating that population density functions as a rough proxy for social distancing [44] .", [["these parameters", "TEST", 72, 88], ["population density functions", "PROBLEM", 106, 134], ["population", "OBSERVATION_MODIFIER", 106, 116], ["density", "OBSERVATION", 117, 124]]], ["Our data indicate that it significantly influences the formation of the bell-shape of the curve describing the pandemic.", [["Our data", "TEST", 0, 8], ["the pandemic", "PROBLEM", 107, 119], ["shape", "OBSERVATION_MODIFIER", 77, 82], ["pandemic", "OBSERVATION_MODIFIER", 111, 119]]], ["By normalizing our data using population density, we found good correlations between the temperature and absolute humidity, and the identified durations.", [["the temperature", "TEST", 85, 100], ["good", "OBSERVATION_MODIFIER", 59, 63]]], ["This is surprising because the ambient conditions in the real world vary significantly with time (e.g., [45] [46] [47] ).", [["the ambient conditions", "PROBLEM", 27, 49]]], ["Regarding ambient condition parameters, the daily maximum absolute humidity had the greatest effect.DiscussionThe parameters obtained with multivariate linear regression analysis were applied for the predictions: adjusted R 2 values are 0.53 (p < 0.05) and 0.24 (p = 0.13) for the spread and decay durations, respectively; that is, the decay duration is not statistically significant.", [["ambient condition parameters", "PROBLEM", 10, 38], ["the daily maximum absolute humidity", "TREATMENT", 40, 75], ["multivariate linear regression analysis", "TEST", 139, 178], ["greatest", "OBSERVATION_MODIFIER", 84, 92]]], ["The small peaks observed in the prefectures adjacent to the primary prefectures (Figure 2b ) could be the potential reason for this.DiscussionThis demonstrates that in adjacent prefectures the influence of the primary prefectures may not be neglected because residents commuting between the prefectures influence the spread and/or decay durations.", [["The small peaks", "PROBLEM", 0, 15], ["small", "OBSERVATION_MODIFIER", 4, 9], ["peaks", "OBSERVATION_MODIFIER", 10, 15]]], ["For example, Hyogo prefectural governor decided to match the end of state emergency with that in Osaka; they are adjacent with each other.DiscussionTherefore, additional constraints were defined to exclude prefectures located adjacent to primary prefectures to avoid the influence of infections caused by neighboring major pandemic clusters.", [["infections", "DISEASE", 284, 294], ["infections", "PROBLEM", 284, 294], ["infections", "OBSERVATION", 284, 294]]], ["A set of nine prefectures demonstrated a strong correlation of the average absolute humidity and population density, yielding adjusted R 2 values of 0.896 (p < 0.05) and 0.681 (p < 0.05) in the spread and decay stages, respectively.DiscussionThe importance of absolute humidity was suggested in previous studies on the morbidity/mortality rate of the influenza virus [48, 49] and also in a preliminary study of COVID-19 [22] .", [["influenza", "DISEASE", 351, 360], ["influenza virus", "ORGANISM", 351, 366], ["influenza virus", "SPECIES", 351, 366], ["influenza virus", "SPECIES", 351, 366], ["population density", "TEST", 97, 115], ["absolute humidity", "TREATMENT", 260, 277], ["the influenza virus", "PROBLEM", 347, 366], ["a preliminary study", "TEST", 388, 407], ["COVID", "TEST", 411, 416], ["population density", "OBSERVATION", 97, 115]]], ["Note that the differences in other parameters, including maximum and average temperatures, and average absolute humidity, show comparable correlations.", [["other parameters", "TEST", 29, 45], ["average temperatures", "TEST", 69, 89], ["average absolute humidity", "TEST", 95, 120], ["maximum", "OBSERVATION_MODIFIER", 57, 64], ["absolute humidity", "OBSERVATION", 103, 120]]], ["In [22] the role of the ambient parameters could not be adequately constrained, and controversies and inconsistencies remained (see the review in \"Introduction\").DiscussionA straightforward comparison of our findings with those of different countries is not feasible because the data is measured based on different closure policies, testing rates, validation measures, etc., which would introduce several biases.", [["the data", "TEST", 275, 283], ["different closure policies", "TREATMENT", 305, 331], ["testing rates", "TEST", 333, 346], ["validation measures", "TREATMENT", 348, 367]]], ["Recently, the effect of air-conditioning units on COVID-19 transmission has also been suggested [50] .", [["COVID-19", "GENE_OR_GENE_PRODUCT", 50, 58], ["air-conditioning units", "TREATMENT", 24, 46], ["COVID", "TREATMENT", 50, 55]]], ["This case study on the pandemic duration in Japan nevertheless provides a highly consistent result that may lead to a better understanding of this correlation.ConclusionsThis study investigates the correlation of the durations of the spread and decay stages of COVID-19 with ambient conditions and population density in 16 prefectures of Japan.", [["This case study", "TEST", 0, 15], ["This study", "TEST", 170, 180], ["COVID", "TEST", 261, 266], ["ambient conditions", "TREATMENT", 275, 293], ["population density", "PROBLEM", 298, 316]]], ["Although the number of cases reported in Japan is limited, the uniformity of the data provides a fairly consistent conclusion; the population density is dominant, and higher absolute humidity and temperature may result in shorter durations.", [["higher absolute humidity", "PROBLEM", 167, 191], ["population", "OBSERVATION_MODIFIER", 131, 141], ["density", "OBSERVATION", 142, 149], ["dominant", "OBSERVATION_MODIFIER", 153, 161], ["higher", "OBSERVATION_MODIFIER", 167, 173], ["absolute humidity", "OBSERVATION", 174, 191]]], ["For a potential pandemic, especially a potential second wave of COVID-19, this factor should be considered as well as the multi-city comparison for developing different protection policies.Conflicts of Interest:The authors declare no conflicts of interest.Appendix AThe relationship between the different ambient condition metrics and morbidity is often discussed (e.g., [51] ).", [["COVID", "TEST", 64, 69], ["different", "OBSERVATION_MODIFIER", 295, 304], ["ambient", "OBSERVATION_MODIFIER", 305, 312], ["condition", "OBSERVATION", 313, 322], ["morbidity", "OBSERVATION", 335, 344]]], ["For the COVID-19 duration analyzed in this study, the correlation between the maximum temperature and maximum absolute humidity in the spread duration presented in Figure A1 are significant (p < 0.05).", [["COVID", "DNA", 8, 13], ["this study", "TEST", 38, 48], ["the maximum temperature", "TEST", 74, 97], ["maximum absolute humidity", "TEST", 102, 127], ["maximum", "OBSERVATION_MODIFIER", 102, 109], ["absolute humidity", "OBSERVATION", 110, 127], ["spread", "OBSERVATION_MODIFIER", 135, 141], ["significant", "OBSERVATION_MODIFIER", 178, 189]]], ["The duration of COVID-19 was generally limited to two months; thus, the metrics considered in the discussion of Figure 6 are correlated unlike the discussion of their annual impact on influenza (e.g., [49] ).Appendix AJapan nevertheless provides a highly consistent result that may lead to a better understanding of this correlation.ConclusionsThis study investigates the correlation of the durations of the spread and decay stages of COVID-19 with ambient conditions and population density in 16 prefectures of Japan.", [["influenza", "DISEASE", 184, 193], ["COVID", "TEST", 16, 21], ["influenza", "PROBLEM", 184, 193], ["This study", "TEST", 344, 354], ["COVID", "TEST", 435, 440], ["ambient conditions", "TREATMENT", 449, 467], ["population density", "PROBLEM", 472, 490]]], ["Although the number of cases reported in Japan is limited, the uniformity of the data provides a fairly consistent conclusion; the population density is dominant, and higher absolute humidity and temperature may result in shorter durations.", [["higher absolute humidity", "PROBLEM", 167, 191], ["population", "OBSERVATION_MODIFIER", 131, 141], ["density", "OBSERVATION", 142, 149], ["dominant", "OBSERVATION_MODIFIER", 153, 161], ["higher", "OBSERVATION_MODIFIER", 167, 173], ["absolute humidity", "OBSERVATION", 174, 191]]], ["For a potential pandemic, especially a potential second wave of COVID-19, this factor should be considered as well as the multi-city comparison for developing different protection policies.Conflicts of Interest:The authors declare no conflicts of interest.Appendix AThe relationship between the different ambient condition metrics and morbidity is often discussed (e.g., [51] ).", [["COVID", "TEST", 64, 69], ["different", "OBSERVATION_MODIFIER", 295, 304], ["ambient", "OBSERVATION_MODIFIER", 305, 312], ["condition", "OBSERVATION", 313, 322], ["morbidity", "OBSERVATION", 335, 344]]], ["For the COVID-19 duration analyzed in this study, the correlation between the maximum temperature and maximum absolute humidity in the spread duration presented in Figure A1 are significant (p < 0.05).", [["COVID", "DNA", 8, 13], ["this study", "TEST", 38, 48], ["the maximum temperature", "TEST", 74, 97], ["maximum absolute humidity", "TEST", 102, 127], ["maximum", "OBSERVATION_MODIFIER", 102, 109], ["absolute humidity", "OBSERVATION", 110, 127], ["spread", "OBSERVATION_MODIFIER", 135, 141], ["significant", "OBSERVATION_MODIFIER", 178, 189]]], ["The duration of COVID-19 was generally limited to two months; thus, the metrics considered in the discussion of Figure 6 are correlated unlike the discussion of their annual impact on influenza (e.g., [49] ).", [["influenza", "DISEASE", 184, 193], ["COVID", "TEST", 16, 21], ["influenza", "PROBLEM", 184, 193]]]], "22d648d299672d11b7e27c67f8da9aa28081808b": [["IntroductionThe LO-relationship extraction task, recently introduced in [8] , seeks to predict the degree of relatedness between learning outcomes (LOs) in a curriculum.", [["LO", "PROTEIN", 16, 18], ["The LO-relationship extraction task", "TREATMENT", 12, 47]]], ["A hierarchy, designed by curriculum experts, groups these LOs at different levels of granularity.", [["hierarchy", "OBSERVATION", 2, 11], ["LOs", "OBSERVATION_MODIFIER", 58, 61], ["granularity", "OBSERVATION", 85, 96]]], ["A successful clinical encounter requires students to conceptually relate and marshal knowledge gained from several LOs, spread across years and across distant parts of the curriculum hierarchy.", [["several LOs", "PROBLEM", 107, 118], ["several", "OBSERVATION_MODIFIER", 107, 114], ["LOs", "OBSERVATION_MODIFIER", 115, 118]]], ["This underscores the need for an automatic LO-relationship extraction tool (hereafter called LReT).IntroductionIn our earlier work [8] , this is abstracted as a classification task, where a pair of LOs is categorized as being strongly related (high degree of conceptual S. Mondal similarity), weakly related (intermediate conceptual similarity), or unrelated (no conceptual similarity).", [["LOs", "DNA", 198, 201], ["an automatic LO-relationship extraction", "TREATMENT", 30, 69], ["high degree", "OBSERVATION_MODIFIER", 244, 255]]], ["An LReT is trained on annotated data obtained from subject matter experts (SMEs), who are both faculty and doctors.IntroductionHowever, this curriculum is periodically reviewed and revised.", [["LReT", "DNA", 3, 7]]], ["Note that the textual formulation (hence underlying concept) of the LO has been modified.", [["LO", "PROTEIN", 68, 70], ["the textual formulation", "TREATMENT", 10, 33]]], ["Additionally, the LO has been re-grouped under a separate set of verticals -Longitudinal Course, Module, and Assessment Type, while doing away with Clinical Block, the only vertical in the previous version.", [["LO", "PROTEIN", 18, 20], ["Clinical Block", "PROBLEM", 148, 162], ["vertical", "OBSERVATION_MODIFIER", 173, 181]]], ["Re-obtaining SME annotations carries appreciable cognitive and cost overheads, making it impractical to train an LReT from scratch.IntroductionWe present a systematic approach towards LO-relationship extraction under curriculum drift.", [["appreciable cognitive and cost overheads", "PROBLEM", 37, 77], ["a systematic approach", "TREATMENT", 154, 175], ["appreciable", "OBSERVATION_MODIFIER", 37, 48], ["scratch", "OBSERVATION", 123, 130], ["curriculum drift", "OBSERVATION", 217, 233]]], ["Beginning with the SME-labelled dataset on the old curriculum, we employ heuristics to create a pseudo-labelled dataset for the revised curriculum.", [["SME-labelled dataset", "DNA", 19, 39]]], ["With some supervision now available, we tune the existing pre-trained model to the nuances of the revised curriculum, and compare its efficacy against human performance.IntroductionThis aligns with existing work on domain adaptation and transfer learning [6, 10] ; both study scenarios where training and test data do not derive from the same distribution.", [["human", "ORGANISM", 151, 156], ["human", "SPECIES", 151, 156], ["human", "SPECIES", 151, 156], ["test data", "TEST", 305, 314]]], ["In contrast, not only do we adapt the model to a modified domain, but also generate data pertinent to this domain, thus eliminating the need for human intervention.", [["human", "ORGANISM", 145, 150], ["human", "SPECIES", 145, 150], ["human", "SPECIES", 145, 150], ["human intervention", "TREATMENT", 145, 163]]], ["This bridges the gap between building a reliable LReT, and deploying it against a changing curriculum landscape.Silver Standard Dataset GenerationStarting with SME-annotated old LO pairs, which serves as the gold-standard dataset, we proceed in two steps.", [["Silver", "CHEMICAL", 112, 118], ["SME-annotated old LO pairs", "DNA", 160, 186], ["Silver Standard Dataset GenerationStarting", "TREATMENT", 112, 154]]], ["First, we define a mapping that links an LO from the old curriculum (OC) to its closest matching counterpart in the revised curriculum (RC):Silver Standard Dataset Generationwhere sim is an appropriate semantic textual similarity metric.", [["a mapping", "TEST", 17, 26]]], ["Intuitively, the mapping score, sim(p, M (p)) captures the extent of semantic drift in the content of an LO.", [["the mapping score", "TEST", 13, 30], ["semantic drift", "PROBLEM", 69, 83], ["semantic drift", "OBSERVATION", 69, 83], ["LO", "OBSERVATION", 105, 107]]], ["Recall that the gold-standard dataset (D old ) consists of old LO pairs (p, q), along with an SME-annotated class label.", [["old LO pairs", "PROBLEM", 59, 71]]], ["A silverstandard dataset for the revised curriculum (D rev ) is derived by pruning the mapping scores of an old LO pair at a pre-defined threshold (\u03c4 ), while retaining its class label.", [["A silverstandard dataset", "TREATMENT", 0, 24]]], ["Formally,Silver Standard Dataset Generation(2) Effectively, we propagate the SME-label from a LO pair in old curriculum to their corresponding maps in the revised curriculum, only if the both mapping scores exceed the threshold.", [["a LO pair in old curriculum", "TREATMENT", 92, 119], ["the both mapping scores", "TEST", 183, 206]]], ["These pseudo-labeled instances constitute the silverstandard dataset.Proposed Model Adaptation ApproachesThe base-model ( Fig. 1(A) ), trained on gold-standard LO pairs of the old curriculum, predicts posterior probabilities for Strong, Weak, and None classes.", [["base", "ANATOMY_MODIFIER", 109, 113], ["posterior", "ANATOMY_MODIFIER", 201, 210], ["Strong", "OBSERVATION_MODIFIER", 229, 235], ["Weak", "OBSERVATION", 237, 241]]], ["As a comparative baseline, we train a model from scratch on the silver-standard dataset, without leveraging the base-model.", [["silver", "CHEMICAL", 64, 70]]], ["We then explore three approaches to adapt base-model: Feature Mapping (MF) , where we manually map features from the revised curriculum to the old curriculum, and drop features that cannot be mapped ( Fig. 1(C) ).", [["drop features", "PROBLEM", 163, 176]]], ["The resultant feature set can be fed to the base-model for predicting LO relatedness in new curriculum.Feature Transformation (FT):In this novel approach (Fig. 1(D) ), we inject a fully connected layer that transforms the revised feature set to an approximate old feature set, which can then be fed to the base-model.", [["base", "ANATOMY_MODIFIER", 44, 48], ["new", "OBSERVATION_MODIFIER", 88, 91]]], ["The silver standard dataset is leveraged to train only this transformation layer, i.e. base-model layers are frozen.Feature Transformation with Smoothing (FT-S):Once the transformation weights converge to an extent, we unfreeze the base-model parameters and train for a few epochs to allow fine-grained updates to the entire network.", [["silver", "CHEMICAL", 4, 10], ["silver", "CHEMICAL", 4, 10], ["silver", "SIMPLE_CHEMICAL", 4, 10], ["layers", "TISSUE", 98, 104], ["The silver standard dataset", "TREATMENT", 0, 27], ["this transformation layer", "PROBLEM", 55, 80], ["Feature Transformation", "PROBLEM", 116, 138], ["layer", "OBSERVATION_MODIFIER", 75, 80], ["layers", "OBSERVATION_MODIFIER", 98, 104]]], ["Table 2a compares model adaptation techniques outlined in Sect.", [["adaptation techniques", "TREATMENT", 24, 45]]], ["All approaches that leverage the base-model outperform training from Scratch, to various degrees.", [["model outperform training", "TREATMENT", 38, 63], ["Scratch", "PROBLEM", 69, 76], ["Scratch", "OBSERVATION", 69, 76]]], ["Feature transformation with smoothing (FT-S) yields the highest macro-F1, thus establishing that a) the base-model encodes some task-specific information independent of the specific curriculum, b) the revised feature-set can be adequately modeled as a linear transformation of the old feature-set, and c) additional smoothing over parameters of the base-model allows it to learn curriculum-specific nuances.Experiments and AnalysisFurthermore, as shown in Table 2b , the high variance in model performance stems from the small size of training and test sets for each cross-validation split, and the macro-F1 score is sensitive to samples in the specific test split.", [["samples", "ANATOMY", 630, 637], ["Feature transformation", "PROBLEM", 0, 22], ["test sets", "TEST", 548, 557], ["each cross-validation", "TEST", 562, 583], ["the macro-F1 score", "TEST", 595, 613], ["the specific test", "TEST", 641, 658], ["base", "ANATOMY_MODIFIER", 349, 353], ["small", "OBSERVATION_MODIFIER", 521, 526], ["size", "OBSERVATION_MODIFIER", 527, 531]]], ["We perform paired t-test to ascertain that except for two pairs, FT vs MF (p = 6.8 \u00d7 10 \u22122 ) and FT vs FT-S (p = 6.6 \u00d7 10 \u22122 ), differences between all other techniquepairs are statistically significant at 95% confidence interval.Experiments and AnalysisFinally, for a small held-out set (n = 229), we obtain annotations separately from two SMEs and compute the inter-annotator agreement (71.7% macro-F1), which serves as a skyline.", [["paired t-test", "TEST", 11, 24], ["FT", "TEST", 65, 67], ["MF", "TEST", 71, 73], ["p", "TEST", 75, 76], ["FT", "TEST", 97, 99], ["FT", "TEST", 103, 105], ["S", "TEST", 106, 107], ["p", "TEST", 109, 110], ["significant", "OBSERVATION_MODIFIER", 191, 202]]], ["As shown in Table 2d , considering one SME as groundtruth and comparing against FT-S's predictions, the human-machine agreement turns out to be 64.4%.", [["human", "ORGANISM", 104, 109], ["human", "SPECIES", 104, 109], ["human", "SPECIES", 104, 109]]], ["Compared to human performance, our reported results are moderately high, with, of course, some further scope of improvement.", [["human", "ORGANISM", 12, 17], ["human", "SPECIES", 12, 17], ["human", "SPECIES", 12, 17], ["moderately", "OBSERVATION_MODIFIER", 56, 66], ["high", "OBSERVATION_MODIFIER", 67, 71]]]], "9e1ef46a7bb068d3363268b4533310acf4b86c0a": [["Diagnosis of Liver Disease in Domestic Ferrets (Mustela Putorius) INTRODUCTION Liver diseases have been extensively described in small animal species and are believed common in pet ferrets (Mustela putorius furo).", [["Liver", "ANATOMY", 13, 18], ["Liver", "ANATOMY", 79, 84], ["Liver Disease", "DISEASE", 13, 26], ["Liver diseases", "DISEASE", 79, 93], ["Liver", "ORGAN", 13, 18], ["Liver", "ORGAN", 79, 84], ["pet ferrets", "ORGANISM", 177, 188], ["Mustela putorius furo", "ORGANISM", 190, 211], ["Mustela", "SPECIES", 48, 55], ["ferrets", "SPECIES", 181, 188], ["Mustela putorius", "SPECIES", 190, 206], ["pet ferrets", "SPECIES", 177, 188], ["Mustela putorius furo", "SPECIES", 190, 211], ["Liver Disease", "PROBLEM", 13, 26], ["Domestic Ferrets", "PROBLEM", 30, 46], ["Liver diseases", "PROBLEM", 79, 93], ["small animal species", "PROBLEM", 129, 149], ["Liver", "ANATOMY", 13, 18], ["Disease", "OBSERVATION", 19, 26], ["Domestic Ferrets", "OBSERVATION", 30, 46], ["Liver", "ANATOMY", 79, 84], ["diseases", "OBSERVATION", 85, 93], ["small", "OBSERVATION_MODIFIER", 129, 134], ["animal species", "OBSERVATION_MODIFIER", 135, 149]]], ["The disease remains often subclinical, which may lead to difficulties in diagnosing those conditions accurately.", [["The disease", "PROBLEM", 0, 11], ["disease", "OBSERVATION", 4, 11]]], ["Blood examination and serum chemistry evaluation are useful tools in screening hepatic pathology and monitoring response to treatment.", [["Blood", "ANATOMY", 0, 5], ["serum", "ANATOMY", 22, 27], ["hepatic", "ANATOMY", 79, 86], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["serum", "ORGANISM_SUBSTANCE", 22, 27], ["hepatic", "ORGAN", 79, 86], ["Blood examination", "TEST", 0, 17], ["serum chemistry evaluation", "TEST", 22, 48], ["screening hepatic pathology", "TEST", 69, 96], ["treatment", "TREATMENT", 124, 133], ["hepatic", "ANATOMY", 79, 86]]], ["Diagnostic imaging allows visualization of liver abnormalities, especially gallbladder and bile duct disease.", [["liver", "ANATOMY", 43, 48], ["gallbladder", "ANATOMY", 75, 86], ["bile duct", "ANATOMY", 91, 100], ["liver abnormalities", "DISEASE", 43, 62], ["gallbladder and bile duct disease", "DISEASE", 75, 108], ["liver", "ORGAN", 43, 48], ["gallbladder", "ORGAN", 75, 86], ["bile duct", "MULTI-TISSUE_STRUCTURE", 91, 100], ["Diagnostic imaging", "TEST", 0, 18], ["liver abnormalities", "PROBLEM", 43, 62], ["gallbladder and bile duct disease", "PROBLEM", 75, 108], ["liver", "ANATOMY", 43, 48], ["abnormalities", "OBSERVATION", 49, 62], ["gallbladder", "ANATOMY", 75, 86], ["bile duct", "ANATOMY", 91, 100]]], ["Ultimately, histopathology is often required for definitive diagnosis and staging of the lesions.", [["lesions", "ANATOMY", 89, 96], ["lesions", "PATHOLOGICAL_FORMATION", 89, 96], ["definitive diagnosis", "TEST", 49, 69], ["staging", "TEST", 74, 81], ["the lesions", "PROBLEM", 85, 96], ["lesions", "OBSERVATION", 89, 96]]], ["Various diseases have been reported: inflammatory, infectious and toxic hepatitis, and hepatic lipidosis.", [["hepatic", "ANATOMY", 87, 94], ["infectious and toxic hepatitis", "DISEASE", 51, 81], ["hepatic lipidosis", "DISEASE", 87, 104], ["hepatic", "ORGAN", 87, 94], ["Various diseases", "PROBLEM", 0, 16], ["inflammatory, infectious", "PROBLEM", 37, 61], ["toxic hepatitis", "PROBLEM", 66, 81], ["hepatic lipidosis", "PROBLEM", 87, 104], ["diseases", "OBSERVATION", 8, 16], ["inflammatory", "OBSERVATION_MODIFIER", 37, 49], ["infectious", "OBSERVATION", 51, 61], ["toxic", "OBSERVATION_MODIFIER", 66, 71], ["hepatitis", "OBSERVATION", 72, 81], ["hepatic", "ANATOMY", 87, 94], ["lipidosis", "OBSERVATION", 95, 104]]], ["Less commonly, neoplasia or other pathology may be seen.", [["neoplasia", "ANATOMY", 15, 24], ["neoplasia", "DISEASE", 15, 24], ["neoplasia", "CANCER", 15, 24], ["neoplasia", "PROBLEM", 15, 24], ["other pathology", "PROBLEM", 28, 43], ["neoplasia", "OBSERVATION", 15, 24], ["pathology", "OBSERVATION", 34, 43], ["may be seen", "UNCERTAINTY", 44, 55]]], ["After a summary of anatomy and physiology of the ferret liver, hepatic diseases known in ferret species are reviewed with their subsequent diagnostic procedures.", [["liver", "ANATOMY", 56, 61], ["hepatic", "ANATOMY", 63, 70], ["hepatic diseases", "DISEASE", 63, 79], ["ferret", "ORGANISM", 49, 55], ["liver", "ORGAN", 56, 61], ["hepatic", "ORGAN", 63, 70], ["ferret", "ORGANISM", 89, 95], ["ferret", "SPECIES", 49, 55], ["ferret", "SPECIES", 89, 95], ["ferret", "SPECIES", 49, 55], ["hepatic diseases", "PROBLEM", 63, 79], ["diagnostic procedures", "TEST", 139, 160], ["liver", "ANATOMY", 56, 61], ["hepatic", "ANATOMY", 63, 70], ["diseases", "OBSERVATION", 71, 79]]]], "PMC7125707": [["Materials and MethodsBetween July 1995 and March 2004, surgical lung biopsy was performed for diagnostic purpose in 269 patients with interstitial lung diseases or unexplained bilateral lung infiltrates at Samsung Medical Center.", [["lung", "ANATOMY", 64, 68], ["interstitial lung", "ANATOMY", 134, 151], ["lung", "ANATOMY", 186, 190], ["interstitial lung diseases", "DISEASE", 134, 160], ["lung biopsy", "MULTI-TISSUE_STRUCTURE", 64, 75], ["patients", "ORGANISM", 120, 128], ["lung", "ORGAN", 147, 151], ["lung", "ORGAN", 186, 190], ["patients", "SPECIES", 120, 128], ["surgical lung biopsy", "TEST", 55, 75], ["diagnostic purpose", "TEST", 94, 112], ["interstitial lung diseases", "PROBLEM", 134, 160], ["unexplained bilateral lung infiltrates", "PROBLEM", 164, 202], ["lung", "ANATOMY", 64, 68], ["biopsy", "OBSERVATION", 69, 75], ["interstitial", "ANATOMY_MODIFIER", 134, 146], ["lung", "ANATOMY", 147, 151], ["diseases", "OBSERVATION", 152, 160], ["bilateral", "ANATOMY_MODIFIER", 176, 185], ["lung", "ANATOMY", 186, 190], ["infiltrates", "OBSERVATION", 191, 202]]], ["Among them, 42 patients were found to have a pathologic diagnosis of DAD.", [["DAD", "DISEASE", 69, 72], ["patients", "ORGANISM", 15, 23], ["patients", "SPECIES", 15, 23], ["DAD", "PROBLEM", 69, 72], ["pathologic", "OBSERVATION", 45, 55]]], ["Internal review board approval for chart review was obtained, and informed consent was waived due to the retrospective nature of the study.", [["the study", "TEST", 129, 138]]], ["Medical records and pathologic findings for these 42 patients were reviewed to diagnose AIP.", [["AIP", "DISEASE", 88, 91], ["patients", "ORGANISM", 53, 61], ["patients", "SPECIES", 53, 61], ["pathologic findings", "TEST", 20, 39]]], ["Our diagnostic criteria for AIP were as follows: (1) acute respiratory failure developing within 2 months; (2) the presence of DAD on surgical lung biopsy specimens; (3) the absence of underlying chronic pulmonary disease or previously abnormal chest radiograph findings; (4) the absence of any known inciting event or predisposing condition for ARDS such as respiratory infection, collagen vascular disease, exposure to environmental or occupational toxic agents, drugs, or radiation, and prior interstitial lung disease; and (5) no recent history of shock or use of vasopressors prior to hospital admission.1, 3, 7, 8", [["respiratory", "ANATOMY", 59, 70], ["lung biopsy specimens", "ANATOMY", 143, 164], ["pulmonary", "ANATOMY", 204, 213], ["chest", "ANATOMY", 245, 250], ["respiratory", "ANATOMY", 359, 370], ["vascular", "ANATOMY", 391, 399], ["interstitial lung", "ANATOMY", 496, 513], ["AIP", "DISEASE", 28, 31], ["respiratory failure", "DISEASE", 59, 78], ["DAD", "DISEASE", 127, 130], ["chronic pulmonary disease", "DISEASE", 196, 221], ["ARDS", "DISEASE", 346, 350], ["respiratory infection", "DISEASE", 359, 380], ["collagen vascular disease", "DISEASE", 382, 407], ["interstitial lung disease", "DISEASE", 496, 521], ["shock", "DISEASE", 552, 557], ["AIP", "CANCER", 28, 31], ["lung biopsy", "MULTI-TISSUE_STRUCTURE", 143, 154], ["pulmonary", "ORGAN", 204, 213], ["collagen", "GENE_OR_GENE_PRODUCT", 382, 390], ["vascular", "MULTI-TISSUE_STRUCTURE", 391, 399], ["lung", "ORGAN", 509, 513], ["AIP", "PROBLEM", 28, 31], ["acute respiratory failure", "PROBLEM", 53, 78], ["surgical lung biopsy specimens", "TEST", 134, 164], ["underlying chronic pulmonary disease", "PROBLEM", 185, 221], ["previously abnormal chest radiograph findings", "PROBLEM", 225, 270], ["any known inciting event", "PROBLEM", 291, 315], ["predisposing condition", "PROBLEM", 319, 341], ["ARDS", "PROBLEM", 346, 350], ["respiratory infection", "PROBLEM", 359, 380], ["collagen vascular disease", "PROBLEM", 382, 407], ["occupational toxic agents", "TREATMENT", 438, 463], ["drugs", "TREATMENT", 465, 470], ["radiation", "TREATMENT", 475, 484], ["prior interstitial lung disease", "PROBLEM", 490, 521], ["shock", "PROBLEM", 552, 557], ["vasopressors", "TREATMENT", 568, 580], ["acute", "OBSERVATION_MODIFIER", 53, 58], ["respiratory", "ANATOMY", 59, 70], ["failure", "OBSERVATION", 71, 78], ["lung", "ANATOMY", 143, 147], ["biopsy", "OBSERVATION", 148, 154], ["chronic", "OBSERVATION_MODIFIER", 196, 203], ["pulmonary", "ANATOMY", 204, 213], ["disease", "OBSERVATION", 214, 221], ["chest", "ANATOMY", 245, 250], ["respiratory", "ANATOMY", 359, 370], ["infection", "OBSERVATION", 371, 380], ["vascular", "ANATOMY", 391, 399], ["interstitial", "ANATOMY_MODIFIER", 496, 508], ["lung", "ANATOMY", 509, 513], ["disease", "OBSERVATION", 514, 521], ["shock", "OBSERVATION", 552, 557]]]], "PMC7498251": [["IntroductionThe ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to more than 23 million confirmed cases and 800 thousand deaths worldwide as of August 24, 2020 (https://covid19.who.int/).", [["coronavirus disease", "DISEASE", 24, 43], ["COVID-19", "CHEMICAL", 50, 58], ["acute respiratory syndrome coronavirus", "DISEASE", 86, 124], ["deaths", "DISEASE", 205, 211], ["coronavirus", "ORGANISM", 24, 35], ["COVID-19", "ORGANISM", 50, 58], ["severe acute respiratory syndrome coronavirus 2", "ORGANISM", 79, 126], ["SARS-CoV-2", "ORGANISM", 128, 138], ["severe acute respiratory syndrome coronavirus", "SPECIES", 79, 124], ["SARS-CoV-2", "SPECIES", 128, 138], ["The ongoing coronavirus disease", "PROBLEM", 12, 43], ["COVID", "TEST", 50, 55], ["pandemic", "PROBLEM", 60, 68], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 79, 124], ["CoV", "TEST", 133, 136], ["coronavirus disease", "OBSERVATION", 24, 43], ["severe", "OBSERVATION_MODIFIER", 79, 85], ["acute", "OBSERVATION_MODIFIER", 86, 91], ["respiratory syndrome", "OBSERVATION", 92, 112]]], ["Emerging data suggest that hypertension, diabetes, and cardiovascular diseases (CVDs) are highly prevalent among patients hospitalized with COVID-19, and that these may be associated with an increased risk of mortality due to the virus.", [["cardiovascular", "ANATOMY", 55, 69], ["hypertension", "DISEASE", 27, 39], ["diabetes", "DISEASE", 41, 49], ["cardiovascular diseases", "DISEASE", 55, 78], ["CVDs", "DISEASE", 80, 84], ["patients", "ORGANISM", 113, 121], ["patients", "SPECIES", 113, 121], ["Emerging data", "TEST", 0, 13], ["hypertension", "PROBLEM", 27, 39], ["diabetes", "PROBLEM", 41, 49], ["cardiovascular diseases", "PROBLEM", 55, 78], ["CVDs", "PROBLEM", 80, 84], ["COVID", "TEST", 140, 145], ["an increased risk of mortality", "PROBLEM", 188, 218], ["the virus", "PROBLEM", 226, 235], ["hypertension", "OBSERVATION", 27, 39], ["diabetes", "OBSERVATION", 41, 49], ["cardiovascular", "ANATOMY", 55, 69], ["diseases", "OBSERVATION", 70, 78], ["increased", "OBSERVATION_MODIFIER", 191, 200], ["virus", "OBSERVATION", 230, 235]]], ["Metabolic associated fatty liver disease (MAFLD) is a well-known risk factor for CVDs and diabetes, and has been closely related to mortality due to these diseases [1,2].", [["fatty liver", "ANATOMY", 21, 32], ["fatty liver disease", "DISEASE", 21, 40], ["MAFLD", "DISEASE", 42, 47], ["CVDs", "DISEASE", 81, 85], ["diabetes", "DISEASE", 90, 98], ["liver", "ORGAN", 27, 32], ["Metabolic associated fatty liver disease", "PROBLEM", 0, 40], ["CVDs", "PROBLEM", 81, 85], ["diabetes", "PROBLEM", 90, 98], ["these diseases", "PROBLEM", 149, 163], ["fatty liver disease", "OBSERVATION", 21, 40], ["diabetes", "OBSERVATION", 90, 98]]], ["MAFLD was reported to affect approximately 20\u201330% of people worldwide [3], [4], [5].", [["MAFLD", "CHEMICAL", 0, 5], ["people", "ORGANISM", 53, 59], ["people", "SPECIES", 53, 59]]], ["Several studies demonstrated that MAFLD could increase disease severity in patients with COVID-19.", [["MAFLD", "CHEMICAL", 34, 39], ["COVID-19", "CHEMICAL", 89, 97], ["MAFLD", "SIMPLE_CHEMICAL", 34, 39], ["patients", "ORGANISM", 75, 83], ["patients", "SPECIES", 75, 83], ["Several studies", "TEST", 0, 15], ["MAFLD", "PROBLEM", 34, 39], ["increase disease severity", "PROBLEM", 46, 71], ["COVID", "TEST", 89, 94], ["increase", "OBSERVATION_MODIFIER", 46, 54], ["disease", "OBSERVATION", 55, 62], ["severity", "OBSERVATION_MODIFIER", 63, 71]]], ["However, Zhou et al. found that MAFLD was not significantly associated with a higher risk of disease severity in young patients [6].", [["patients", "ORGANISM", 119, 127], ["patients", "SPECIES", 119, 127], ["disease severity", "PROBLEM", 93, 109], ["disease", "OBSERVATION", 93, 100]]], ["Therefore, in order to clarify the role of MAFLD among patients with COVID-19, we conducted a meta-analysis to summarize the existing evidence about the pooled prevalence of MAFLD, as well as the association between MAFLD and disease severity among patients with COVID-19.Search strategy ::: MethodsWe conducted a literature search using PubMed, EMBASE, Medline(OVID), and MedRxiv from inception to July 6, 2020.", [["MAFLD", "DISEASE", 43, 48], ["MAFLD", "DISEASE", 174, 179], ["MAFLD", "DISEASE", 216, 221], ["MAFLD", "GENE_OR_GENE_PRODUCT", 43, 48], ["patients", "ORGANISM", 55, 63], ["patients", "ORGANISM", 249, 257], ["patients", "SPECIES", 55, 63], ["patients", "SPECIES", 249, 257], ["COVID", "TEST", 69, 74], ["MAFLD", "PROBLEM", 174, 179], ["disease severity", "PROBLEM", 226, 242], ["COVID", "TEST", 263, 268], ["disease", "OBSERVATION", 226, 233]]], ["We used keywords and MeSH terms to retrieve potential suitable papers, including \u201cSARS-COV-2\u201d, \u201cCOVID-19\u201d, \u201cmetabolic associated fatty liver disease\u201d, \u201cnonalcoholic fatty liver disease (NAFLD)\u201d, and \u201cnonalcoholic steatohepatitis (NASH)\u201d.", [["fatty liver", "ANATOMY", 129, 140], ["nonalcoholic fatty liver", "ANATOMY", 152, 176], ["fatty liver disease", "DISEASE", 129, 148], ["nonalcoholic fatty liver disease", "DISEASE", 152, 184], ["NAFLD", "DISEASE", 186, 191], ["nonalcoholic steatohepatitis", "DISEASE", 200, 228], ["NASH", "DISEASE", 230, 234], ["COV-2", "CELL", 87, 92], ["COVID-19", "CELL", 96, 104], ["liver", "ORGAN", 135, 140], ["liver", "ORGAN", 171, 176], ["COV", "TEST", 87, 90], ["COVID", "TEST", 96, 101], ["fatty liver disease", "PROBLEM", 129, 148], ["nonalcoholic fatty liver disease (NAFLD)", "PROBLEM", 152, 192], ["\u201cnonalcoholic steatohepatitis", "PROBLEM", 199, 228], ["fatty liver disease", "OBSERVATION", 129, 148], ["liver", "ANATOMY", 171, 176], ["nonalcoholic", "OBSERVATION_MODIFIER", 200, 212], ["steatohepatitis", "OBSERVATION", 213, 228], ["NASH", "OBSERVATION", 230, 234]]]], "PMC7159383": [["IntroductionDendritic cells (DC) are now recognized as essential regulators of both innate and acquired arms of the immune system.1Dendritic cells, in addition to their distinctive morphology, have a number of phenotypic and functional characteristics that make them formidable APC (Table 1).", [["IntroductionDendritic cells", "ANATOMY", 0, 27], ["DC", "ANATOMY", 29, 31], ["immune system", "ANATOMY", 116, 129], ["Dendritic cells", "ANATOMY", 131, 146], ["IntroductionDendritic cells", "CELL", 0, 27], ["DC", "CELL", 29, 31], ["immune system", "ANATOMICAL_SYSTEM", 116, 129], ["Dendritic cells", "CELL", 131, 146], ["APC", "GENE_OR_GENE_PRODUCT", 278, 281], ["IntroductionDendritic cells", "CELL_TYPE", 0, 27], ["DC", "CELL_TYPE", 29, 31], ["Dendritic cells", "CELL_TYPE", 131, 146], ["APC", "CELL_TYPE", 278, 281], ["IntroductionDendritic cells", "PROBLEM", 0, 27], ["Dendritic cells", "PROBLEM", 131, 146], ["distinctive", "OBSERVATION_MODIFIER", 169, 180], ["morphology", "OBSERVATION_MODIFIER", 181, 191]]], ["Dendritic cells bear sole responsibility for the stimulation of virgin T lymphocytes, a property that distinguishes them from all other APC (e.g. B cells).2", [["Dendritic cells", "ANATOMY", 0, 15], ["T lymphocytes", "ANATOMY", 71, 84], ["B cells", "ANATOMY", 146, 153], ["Dendritic cells", "CELL", 0, 15], ["virgin T lymphocytes", "CELL", 64, 84], ["APC", "GENE_OR_GENE_PRODUCT", 136, 139], ["B cells", "CELL", 146, 153], ["Dendritic cells", "CELL_TYPE", 0, 15], ["virgin T lymphocytes", "CELL_TYPE", 64, 84], ["APC", "CELL_TYPE", 136, 139], ["B cells", "CELL_TYPE", 146, 153], ["Dendritic cells", "PROBLEM", 0, 15]]]], "PMC7125577": [["RNA viruses infect vertebrates and lead to a variety of diseases.", [["RNA viruses infect vertebrates", "PROBLEM", 0, 30], ["diseases", "PROBLEM", 56, 64], ["viruses", "OBSERVATION", 4, 11], ["variety", "OBSERVATION_MODIFIER", 45, 52], ["diseases", "OBSERVATION", 56, 64]]], ["Many emerging or re-emerging infectious diseases, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Ebola hemorrhagic fever, are caused by RNA viruses.", [["infectious diseases", "DISEASE", 29, 48], ["acute respiratory syndrome", "DISEASE", 65, 91], ["SARS", "DISEASE", 93, 97], ["Middle East respiratory syndrome", "DISEASE", 100, 132], ["MERS", "DISEASE", 134, 138], ["Ebola hemorrhagic fever", "DISEASE", 145, 168], ["Ebola hemorrhagic fever", "SPECIES", 145, 168], ["Middle East respiratory syndrome (MERS)", "SPECIES", 100, 139], ["re-emerging infectious diseases", "PROBLEM", 17, 48], ["severe acute respiratory syndrome", "PROBLEM", 58, 91], ["SARS)", "PROBLEM", 93, 98], ["Middle East respiratory syndrome", "PROBLEM", 100, 132], ["Ebola hemorrhagic fever", "PROBLEM", 145, 168], ["RNA viruses", "PROBLEM", 184, 195], ["infectious", "OBSERVATION", 29, 39], ["severe", "OBSERVATION_MODIFIER", 58, 64], ["acute", "OBSERVATION_MODIFIER", 65, 70], ["respiratory syndrome", "OBSERVATION", 71, 91], ["Middle", "ANATOMY_MODIFIER", 100, 106], ["respiratory syndrome", "OBSERVATION", 112, 132], ["Ebola", "OBSERVATION_MODIFIER", 145, 150], ["hemorrhagic", "OBSERVATION_MODIFIER", 151, 162], ["fever", "OBSERVATION", 163, 168], ["RNA viruses", "OBSERVATION", 184, 195]]], ["Our current knowledge of the diversity of RNA viruses in vertebrates is rather fragmentary and biased.", [["RNA viruses", "PROBLEM", 42, 53], ["RNA viruses", "OBSERVATION", 42, 53], ["fragmentary", "OBSERVATION", 79, 90]]], ["A large proportion of known vertebrate RNA viruses were isolated from humans or species of economical or medical importance, mainly mammals and birds.", [["humans", "ORGANISM", 70, 76], ["humans", "SPECIES", 70, 76], ["humans", "SPECIES", 70, 76], ["known vertebrate RNA viruses", "PROBLEM", 22, 50], ["large", "OBSERVATION_MODIFIER", 2, 7], ["vertebrate RNA viruses", "OBSERVATION", 28, 50]]], ["Relatively few viruses have been documented in other vertebrate species.", [["Relatively few viruses", "PROBLEM", 0, 22], ["few", "OBSERVATION_MODIFIER", 11, 14], ["viruses", "OBSERVATION", 15, 22], ["vertebrate species", "OBSERVATION", 53, 71]]], ["With the advent of next-generation sequencing (NGS) techniques, more and more novel RNA viruses have been found through meta-genomic or meta-transcriptomic approaches [1].", [["next-generation sequencing (NGS) techniques", "TREATMENT", 19, 62], ["more novel RNA viruses", "PROBLEM", 73, 95]]], ["Moreover, paleovirological studies discovered a large number of ancient RNA viral relics, namely endogenous RNA viral elements, within vertebrate genomes, providing important insights into the deep history of RNA viruses [2].", [["RNA viral relics", "DNA", 72, 88], ["endogenous RNA viral elements", "DNA", 97, 126], ["paleovirological studies", "TEST", 10, 34], ["ancient RNA viral relics", "PROBLEM", 64, 88], ["endogenous RNA viral elements", "PROBLEM", 97, 126], ["RNA viruses", "PROBLEM", 209, 220], ["large", "OBSERVATION_MODIFIER", 48, 53], ["viral relics", "OBSERVATION", 76, 88], ["endogenous RNA", "OBSERVATION", 97, 111], ["viral elements", "OBSERVATION", 112, 126], ["RNA viruses", "OBSERVATION", 209, 220]]], ["However, much remains unknown about the diversity of RNA viruses in vertebrates.", [["RNA viruses in vertebrates", "PROBLEM", 53, 79], ["RNA viruses", "OBSERVATION", 53, 64]]], ["A recent study by Shi et al. [3] greatly expands our understanding of the diversity of RNA viruses in vertebrates.", [["A recent study", "TEST", 0, 14], ["RNA viruses in vertebrates", "PROBLEM", 87, 113], ["RNA viruses", "OBSERVATION", 87, 98]]]]}